Vaccines or candidate vaccines used to prevent infection with ROTAVIRUS.
A genus of REOVIRIDAE, causing acute gastroenteritis in BIRDS and MAMMALS, including humans. Transmission is horizontal and by environmental contamination. Seven species (Rotaviruses A thru G) are recognized.
Infection with any of the rotaviruses. Specific infections include human infantile diarrhea, neonatal calf diarrhea, and epidemic diarrhea of infant mice.
INFLAMMATION of any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Causes of gastroenteritis are many including genetic, infection, HYPERSENSITIVITY, drug effects, and CANCER.
A form of intestinal obstruction caused by the PROLAPSE of a part of the intestine into the adjoining intestinal lumen. There are four types: colic, involving segments of the LARGE INTESTINE; enteric, involving only the SMALL INTESTINE; ileocecal, in which the ILEOCECAL VALVE prolapses into the CECUM, drawing the ILEUM along with it; and ileocolic, in which the ileum prolapses through the ileocecal valve into the COLON.
Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity.
Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases.
Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease.
Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis.
An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.
Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins.
DIARRHEA occurring in infants from newborn to 24-months old.
Two or more vaccines in a single dosage form.
Schedule giving optimum times usually for primary and/or secondary immunization.
Viruses containing two or more pieces of nucleic acid (segmented genome) from different parents. Such viruses are produced in cells coinfected with different strains of a given virus.
Immunoglobulins produced in response to VIRAL ANTIGENS.
Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
Proteins that form the CAPSID of VIRUSES.
Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified.
Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers.
Organized services to administer immunization procedures in the prevention of various diseases. The programs are made available over a wide range of sites: schools, hospitals, public health agencies, voluntary health agencies, etc. They are administered to an equally wide range of population groups or on various administrative levels: community, municipal, state, national, international.
Removal of a drug from the market due to the identification of an intrinsic property of the drug that results in a serious risk to public health.
Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease.
I'm sorry for any confusion, but "Nicaragua" is not a medical term and does not have a medical definition. Nicaragua is the largest country in the Central American isthmus, bordering Honduras to the north and Costa Rica to the south. It has both Atlantic and Pacific coasts. The term you might be looking for is "Nicotine," which is a highly addictive stimulant found in tobacco leaves and is used as an ingredient in various products, including cigarettes, smokeless tobacco, and some medications.
An infant during the first month after birth.
Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent or treat AIDS. Some vaccines containing antigens are recombinantly produced.
Substances elaborated by viruses that have antigenic activity.
Studies designed to assess the efficacy of programs. They may include the evaluation of cost-effectiveness, the extent to which objectives are met, or impact.
The relationship between an elicited ADAPTIVE IMMUNE RESPONSE and the dose of the vaccine administered.
Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognized by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection.
Vaccines consisting of one or more antigens that stimulate a strong immune response. They are purified from microorganisms or produced by recombinant DNA techniques, or they can be chemically synthesized peptides.
The confinement of a patient in a hospital.
Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions.
The geographic area of Latin America in general and when the specific country or countries are not indicated. It usually includes Central America, South America, Mexico, and the islands of the Caribbean.
Surveillance of drugs, devices, appliances, etc., for efficacy or adverse effects, after they have been released for general sale.
A vaccine consisting of DIPHTHERIA TOXOID; TETANUS TOXOID; and whole-cell PERTUSSIS VACCINE. The vaccine protects against diphtheria, tetanus, and whooping cough.
The giving of drugs, chemicals, or other substances by mouth.
Countries that have reached a level of economic achievement through an increase of production, per capita income and consumption, and utilization of natural and human resources.
A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)
The term "United States" in a medical context often refers to the country where a patient or study participant resides, and is not a medical term per se, but relevant for epidemiological studies, healthcare policies, and understanding differences in disease prevalence, treatment patterns, and health outcomes across various geographic locations.
The expelling of virus particles from the body. Important routes include the respiratory tract, genital tract, and intestinal tract. Virus shedding is an important means of vertical transmission (INFECTIOUS DISEASE TRANSMISSION, VERTICAL).
Vaccines made from antigens arising from any of the four strains of Plasmodium which cause malaria in humans, or from P. berghei which causes malaria in rodents.
Process of determining and distinguishing species of bacteria or viruses based on antigens they share.
Live vaccines prepared from microorganisms without their virulence altered. Examples include smallpox (vaccinia) and adenovirus vaccines.
Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.
The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50).
Any immunization following a primary immunization and involving exposure to the same or a closely related antigen.
Divisions of the year according to some regularly recurrent phenomena usually astronomical or climatic. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
Animals not contaminated by or associated with any foreign organisms.
Countries in the process of change with economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures.
I'm sorry for any confusion, but "Uzbekistan" is a country located in Central Asia and it is not a medical term or concept. Therefore, it doesn't have a medical definition.
Vaccines or candidate vaccines used to prevent infection with NEISSERIA MENINGITIDIS.
A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.
Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced.
Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow).
I'm sorry for any confusion, but "Mexico" is not a medical term and does not have a medical definition. It is the name of a country located in North America, known officially as the United Mexican States. If you have any questions related to medical topics or terminology, I would be happy to help answer those!
A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed)
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.
The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.
The process of formulating, improving, and expanding educational, managerial, or service-oriented work plans (excluding computer program development).
A suspension of killed Bordetella pertussis organisms, used for immunization against pertussis (WHOOPING COUGH). It is generally used in a mixture with diphtheria and tetanus toxoids (DTP). There is an acellular pertussis vaccine prepared from the purified antigenic components of Bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. (From Dorland, 28th ed)
Philadelphia, in a medical context, does not have a specific definition as it is a city and not a term used for diagnosis or clinical condition; however, it is known for being the location of several major hospitals and medical institutions, including the University of Pennsylvania Health System and the Children's Hospital of Philadelphia.
Special hospitals which provide care for ill children.
Vaccines or candidate vaccines containing antigenic polysaccharides from Haemophilus influenzae and designed to prevent infection. The vaccine can contain the polysaccharides alone or more frequently polysaccharides conjugated to carrier molecules. It is also seen as a combined vaccine with diphtheria-tetanus-pertussis vaccine.
An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.
An active immunizing agent and a viable avirulent attenuated strain of Mycobacterium tuberculosis, var. bovis, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity.
Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis.
A suspension of formalin-inactivated poliovirus grown in monkey kidney cell tissue culture and used to prevent POLIOMYELITIS.
Systems developed for collecting reports from government agencies, manufacturers, hospitals, physicians, and other sources on adverse drug reactions.
I'm sorry for any confusion, but "India" is not a medical term that can be defined in a medical context. It is a geographical location, referring to the Republic of India, a country in South Asia. If you have any questions related to medical topics or definitions, I would be happy to help with those!
Vaccines or candidate vaccines used to prevent infection with VIBRIO CHOLERAE. The original cholera vaccine consisted of killed bacteria, but other kinds of vaccines now exist.
A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.
The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
Specific, characterizable, poisonous chemicals, often PROTEINS, with specific biological properties, including immunogenicity, produced by microbes, higher plants (PLANTS, TOXIC), or ANIMALS.
A live VACCINIA VIRUS vaccine of calf lymph or chick embryo origin, used for immunization against smallpox. It is now recommended only for laboratory workers exposed to smallpox virus. Certain countries continue to vaccinate those in the military service. Complications that result from smallpox vaccination include vaccinia, secondary bacterial infections, and encephalomyelitis. (Dorland, 28th ed)
A republic in southern Africa east of ZAMBIA and MOZAMBIQUE. Its capital is Lilongwe. It was formerly called Nyasaland.
Vaccines used to prevent TYPHOID FEVER and/or PARATYPHOID FEVER which are caused by various species of SALMONELLA. Attenuated, subunit, and inactivated forms of the vaccines exist.
The outer protein protective shell of a virus, which protects the viral nucleic acid.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
The personal cost of acute or chronic disease. The cost to the patient may be an economic, social, or psychological cost or personal loss to self, family, or immediate community. The cost of illness may be reflected in absenteeism, productivity, response to treatment, peace of mind, or QUALITY OF LIFE. It differs from HEALTH CARE COSTS, meaning the societal cost of providing services related to the delivery of health care, rather than personal impact on individuals.
A specialized agency of the United Nations designed as a coordinating authority on international health work; its aim is to promote the attainment of the highest possible level of health by all peoples.
A live, attenuated varicella virus vaccine used for immunization against chickenpox. It is recommended for children between the ages of 12 months and 13 years.
Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol.
Vaccines or candidate vaccines used to prevent or treat TUBERCULOSIS.
Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy.
Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.
An acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus (POLIOVIRUS). Usually the infection is limited to the gastrointestinal tract and nasopharynx, and is often asymptomatic. The central nervous system, primarily the spinal cord, may be affected, leading to rapidly progressive paralysis, coarse FASCICULATION and hyporeflexia. Motor neurons are primarily affected. Encephalitis may also occur. The virus replicates in the nervous system, and may cause significant neuronal loss, most notably in the spinal cord. A rare related condition, nonpoliovirus poliomyelitis, may result from infections with nonpoliovirus enteroviruses. (From Adams et al., Principles of Neurology, 6th ed, pp764-5)
Vaccines used to prevent infection by MUMPS VIRUS. Best known is the live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.
Vaccines or candidate vaccines used to prevent infection with hepatitis A virus (HEPATOVIRUS).
I'm sorry for any confusion, but "Brazil" is not a medical term or concept, it is a country located in South America, known officially as the Federative Republic of Brazil. If you have any questions related to health, medicine, or science, I'd be happy to help answer those!
The largest of the continents. It was known to the Romans more specifically as what we know today as Asia Minor. The name comes from at least two possible sources: from the Assyrian asu (to rise) or from the Sanskrit usa (dawn), both with reference to its being the land of the rising sun, i.e., eastern as opposed to Europe, to the west. (From Webster's New Geographical Dictionary, 1988, p82 & Room, Brewer's Dictionary of Names, 1992, p34)
The relationships of groups of organisms as reflected by their genetic makeup.
A combined vaccine used to prevent MEASLES; MUMPS; and RUBELLA.
Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information.
Proteins encoded by a VIRAL GENOME that are produced in the organisms they infect, but not packaged into the VIRUS PARTICLES. Some of these proteins may play roles within the infected cell during VIRUS REPLICATION or act in regulation of virus replication or VIRUS ASSEMBLY.
A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell.
Inbred BALB/c mice are a strain of laboratory mice that have been selectively bred to be genetically identical to each other, making them useful for scientific research and experiments due to their consistent genetic background and predictable responses to various stimuli or treatments.
Vaccines or candidate vaccines used to prevent STREPTOCOCCAL INFECTIONS.
A medical specialty concerned with maintaining health and providing medical care to children from birth to adolescence.
Vaccines or candidate vaccines used to prevent ANTHRAX.
Vaccines or candidate vaccines used to prevent infection with DENGUE VIRUS. These include live-attenuated, subunit, DNA, and inactivated vaccines.
Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.
Elements of limited time intervals, contributing to particular results or situations.
Vaccines using VIROSOMES as the antigen delivery system that stimulates the desired immune response.

Rotavirus vaccines are preventive measures used to protect against rotavirus infections, which are the leading cause of severe diarrhea and dehydration among infants and young children worldwide. These vaccines contain weakened or inactivated forms of the rotavirus, a pathogen that infects and causes symptoms by multiplying inside cells lining the small intestine.

The weakened or inactivated virus in the vaccine stimulates an immune response in the body, enabling it to recognize and fight off future rotavirus infections more effectively. The vaccines are usually administered orally, as a liquid droplet or on a sugar cube, to mimic natural infection through the gastrointestinal tract.

There are currently two licensed rotavirus vaccines available globally:

1. Rotarix (GlaxoSmithKline): This vaccine contains an attenuated (weakened) strain of human rotavirus and is given in a two-dose series, typically at 2 and 4 months of age.
2. RotaTeq (Merck): This vaccine contains five reassortant viruses, combining human and animal strains to provide broader protection. It is administered in a three-dose series, usually at 2, 4, and 6 months of age.

Rotavirus vaccines have been shown to significantly reduce the incidence of severe rotavirus gastroenteritis and related hospitalizations among infants and young children. The World Health Organization (WHO) recommends the inclusion of rotavirus vaccination in national immunization programs, particularly in countries with high child mortality rates due to diarrheal diseases.

Rotavirus is a genus of double-stranded RNA virus in the Reoviridae family, which is a leading cause of severe diarrhea and gastroenteritis in young children and infants worldwide. The virus infects and damages the cells lining the small intestine, resulting in symptoms such as vomiting, watery diarrhea, abdominal cramps, and fever.

Rotavirus is highly contagious and can be spread through contact with infected individuals or contaminated surfaces, food, or water. The virus is typically transmitted via the fecal-oral route, meaning that it enters the body through the mouth after coming into contact with contaminated hands, objects, or food.

Rotavirus infections are often self-limiting and resolve within a few days to a week, but severe cases can lead to dehydration, hospitalization, and even death, particularly in developing countries where access to medical care and rehydration therapy may be limited. Fortunately, there are effective vaccines available that can prevent rotavirus infection and reduce the severity of symptoms in those who do become infected.

According to the World Health Organization (WHO), Rotavirus is the most common cause of severe diarrhea among children under 5 years of age. It is responsible for around 215,000 deaths among children in this age group each year.

Rotavirus infection causes inflammation of the stomach and intestines, resulting in symptoms such as vomiting, watery diarrhea, and fever. The virus is transmitted through the fecal-oral route, often through contaminated hands, food, or water. It can also be spread through respiratory droplets when an infected person coughs or sneezes.

Rotavirus infections are highly contagious and can spread rapidly in communities, particularly in settings where children are in close contact with each other, such as child care centers and schools. The infection is usually self-limiting and resolves within a few days, but severe cases can lead to dehydration and require hospitalization.

Prevention measures include good hygiene practices, such as handwashing with soap and water, safe disposal of feces, and rotavirus vaccination. The WHO recommends the inclusion of rotavirus vaccines in national immunization programs to reduce the burden of severe diarrhea caused by rotavirus infection.

Gastroenteritis is not a medical condition itself, but rather a symptom-based description of inflammation in the gastrointestinal tract, primarily involving the stomach and intestines. It's often referred to as "stomach flu," although it's not caused by influenza virus.

Medically, gastroenteritis is defined as an inflammation of the mucous membrane of the stomach and intestines, usually resulting in symptoms such as diarrhea, abdominal cramps, nausea, vomiting, fever, and dehydration. This condition can be caused by various factors, including viral (like rotavirus or norovirus), bacterial (such as Salmonella, Shigella, or Escherichia coli), or parasitic infections, food poisoning, allergies, or the use of certain medications.

Gastroenteritis is generally self-limiting and resolves within a few days with proper hydration and rest. However, severe cases may require medical attention to prevent complications like dehydration, which can be particularly dangerous for young children, older adults, and individuals with weakened immune systems.

Intussusception is a medical condition in which a part of the intestine telescopes into an adjacent section, leading to bowel obstruction and reduced blood flow. It often affects children under 3 years old but can also occur in adults. If not treated promptly, it can result in serious complications such as perforation, peritonitis, or even death. The exact cause is usually unknown, but it may be associated with infections, intestinal disorders, or tumors.

Attenuated vaccines consist of live microorganisms that have been weakened (attenuated) through various laboratory processes so they do not cause disease in the majority of recipients but still stimulate an immune response. The purpose of attenuation is to reduce the virulence or replication capacity of the pathogen while keeping it alive, allowing it to retain its antigenic properties and induce a strong and protective immune response.

Examples of attenuated vaccines include:

1. Sabin oral poliovirus vaccine (OPV): This vaccine uses live but weakened polioviruses to protect against all three strains of the disease-causing poliovirus. The weakened viruses replicate in the intestine and induce an immune response, which provides both humoral (antibody) and cell-mediated immunity.
2. Measles, mumps, and rubella (MMR) vaccine: This combination vaccine contains live attenuated measles, mumps, and rubella viruses. It is given to protect against these three diseases and prevent their spread in the population.
3. Varicella (chickenpox) vaccine: This vaccine uses a weakened form of the varicella-zoster virus, which causes chickenpox. By introducing this attenuated virus into the body, it stimulates an immune response that protects against future infection with the wild-type virus.
4. Yellow fever vaccine: This live attenuated vaccine is used to prevent yellow fever, a viral disease transmitted by mosquitoes in tropical and subtropical regions of Africa and South America. The vaccine contains a weakened form of the yellow fever virus that cannot cause the disease but still induces an immune response.
5. Bacillus Calmette-Guérin (BCG) vaccine: This live attenuated vaccine is used to protect against tuberculosis (TB). It contains a weakened strain of Mycobacterium bovis, which does not cause TB in humans but stimulates an immune response that provides some protection against the disease.

Attenuated vaccines are generally effective at inducing long-lasting immunity and can provide robust protection against targeted diseases. However, they may pose a risk for individuals with weakened immune systems, as the attenuated viruses or bacteria could potentially cause illness in these individuals. Therefore, it is essential to consider an individual's health status before administering live attenuated vaccines.

A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. It typically contains an agent that resembles the disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it encounters in the future.

Vaccines can be prophylactic (to prevent or ameliorate the effects of a future infection by a natural or "wild" pathogen), or therapeutic (to fight disease that is already present). The administration of vaccines is called vaccination. Vaccinations are generally administered through needle injections, but can also be administered by mouth or sprayed into the nose.

The term "vaccine" comes from Edward Jenner's 1796 use of cowpox to create immunity to smallpox. The first successful vaccine was developed in 1796 by Edward Jenner, who showed that milkmaids who had contracted cowpox did not get smallpox. He reasoned that exposure to cowpox protected against smallpox and tested his theory by injecting a boy with pus from a cowpox sore and then exposing him to smallpox, which the boy did not contract. The word "vaccine" is derived from Variolae vaccinae (smallpox of the cow), the term devised by Jenner to denote cowpox. He used it in 1798 during a conversation with a fellow physician and later in the title of his 1801 Inquiry.

A viral vaccine is a biological preparation that introduces your body to a specific virus in a way that helps your immune system build up protection against the virus without causing the illness. Viral vaccines can be made from weakened or inactivated forms of the virus, or parts of the virus such as proteins or sugars. Once introduced to the body, the immune system recognizes the virus as foreign and produces an immune response, including the production of antibodies. These antibodies remain in the body and provide immunity against future infection with that specific virus.

Viral vaccines are important tools for preventing infectious diseases caused by viruses, such as influenza, measles, mumps, rubella, polio, hepatitis A and B, rabies, rotavirus, chickenpox, shingles, and some types of cancer. Vaccination programs have led to the control or elimination of many infectious diseases that were once common.

It's important to note that viral vaccines are not effective against bacterial infections, and separate vaccines must be developed for each type of virus. Additionally, because viruses can mutate over time, it is necessary to update some viral vaccines periodically to ensure continued protection.

Vaccination is a simple, safe, and effective way to protect people against harmful diseases, before they come into contact with them. It uses your body's natural defenses to build protection to specific infections and makes your immune system stronger.

A vaccination usually contains a small, harmless piece of a virus or bacteria (or toxins produced by these germs) that has been made inactive or weakened so it won't cause the disease itself. This piece of the germ is known as an antigen. When the vaccine is introduced into the body, the immune system recognizes the antigen as foreign and produces antibodies to fight it.

If a person then comes into contact with the actual disease-causing germ, their immune system will recognize it and immediately produce antibodies to destroy it. The person is therefore protected against that disease. This is known as active immunity.

Vaccinations are important for both individual and public health. They prevent the spread of contagious diseases and protect vulnerable members of the population, such as young children, the elderly, and people with weakened immune systems who cannot be vaccinated or for whom vaccination is not effective.

Diarrhea is a condition in which an individual experiences loose, watery stools frequently, often exceeding three times a day. It can be acute, lasting for several days, or chronic, persisting for weeks or even months. Diarrhea can result from various factors, including viral, bacterial, or parasitic infections, food intolerances, medications, and underlying medical conditions such as inflammatory bowel disease or irritable bowel syndrome. Dehydration is a potential complication of diarrhea, particularly in severe cases or in vulnerable populations like young children and the elderly.

Inactivated vaccines, also known as killed or non-live vaccines, are created by using a version of the virus or bacteria that has been grown in a laboratory and then killed or inactivated with chemicals, heat, or radiation. This process renders the organism unable to cause disease, but still capable of stimulating an immune response when introduced into the body.

Inactivated vaccines are generally considered safer than live attenuated vaccines since they cannot revert back to a virulent form and cause illness. However, they may require multiple doses or booster shots to maintain immunity because the immune response generated by inactivated vaccines is not as robust as that produced by live vaccines. Examples of inactivated vaccines include those for hepatitis A, rabies, and influenza (inactivated flu vaccine).

Infantile diarrhea is a medical condition characterized by loose, watery stools in infants and young children. It can be caused by various factors such as viral or bacterial infections, food intolerances, allergies, or malabsorption disorders. In some cases, it may also be associated with certain medications or underlying medical conditions.

Infantile diarrhea can lead to dehydration and other complications if not treated promptly and properly. It is important to monitor the infant's hydration status by checking for signs of dehydration such as dry mouth, sunken eyes, and decreased urine output. If diarrhea persists or is accompanied by vomiting, fever, or other concerning symptoms, it is recommended to seek medical attention promptly.

Treatment for infantile diarrhea typically involves rehydration with oral electrolyte solutions, as well as addressing the underlying cause of the diarrhea if possible. In severe cases, hospitalization and intravenous fluids may be necessary.

Combined vaccines are defined in medical terms as vaccines that contain two or more antigens from different diseases, which are given to provide protection against multiple diseases at the same time. This approach reduces the number of injections required and simplifies the immunization schedule, especially during early childhood. Examples of combined vaccines include:

1. DTaP-Hib-IPV (e.g., Pentacel): A vaccine that combines diphtheria, tetanus, pertussis (whooping cough), Haemophilus influenzae type b (Hib) disease, and poliovirus components in one injection to protect against these five diseases.
2. MMRV (e.g., ProQuad): A vaccine that combines measles, mumps, rubella, and varicella (chickenpox) antigens in a single injection to provide immunity against all four diseases.
3. HepA-HepB (e.g., Twinrix): A vaccine that combines hepatitis A and hepatitis B antigens in one injection, providing protection against both types of hepatitis.
4. MenACWY-TT (e.g., MenQuadfi): A vaccine that combines four serogroups of meningococcal bacteria (A, C, W, Y) with tetanus toxoid as a carrier protein in one injection for the prevention of invasive meningococcal disease caused by these serogroups.
5. PCV13-PPSV23 (e.g., Vaxneuvance): A vaccine that combines 13 pneumococcal serotypes with PPSV23, providing protection against a broader range of pneumococcal diseases in adults aged 18 years and older.

Combined vaccines have been thoroughly tested for safety and efficacy to ensure they provide a strong immune response and an acceptable safety profile. They are essential tools in preventing various infectious diseases and improving overall public health.

An immunization schedule is a series of planned dates when a person, usually a child, should receive specific vaccines in order to be fully protected against certain preventable diseases. The schedule is developed based on scientific research and recommendations from health organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC).

The immunization schedule outlines which vaccines are recommended, the number of doses required, the age at which each dose should be given, and the minimum amount of time that must pass between doses. The schedule may vary depending on factors such as the individual's age, health status, and travel plans.

Immunization schedules are important for ensuring that individuals receive timely protection against vaccine-preventable diseases, and for maintaining high levels of immunity in populations, which helps to prevent the spread of disease. It is important to follow the recommended immunization schedule as closely as possible to ensure optimal protection.

Reassortant viruses are formed when two or more different strains of a virus infect the same cell and exchange genetic material, creating a new strain. This phenomenon is most commonly observed in segmented RNA viruses, such as influenza A and B viruses, where each strain may have a different combination of gene segments. When these reassortant viruses emerge, they can sometimes have altered properties, such as increased transmissibility or virulence, which can pose significant public health concerns. For example, pandemic influenza viruses often arise through the process of reassortment between human and animal strains.

Antibodies, viral are proteins produced by the immune system in response to an infection with a virus. These antibodies are capable of recognizing and binding to specific antigens on the surface of the virus, which helps to neutralize or destroy the virus and prevent its replication. Once produced, these antibodies can provide immunity against future infections with the same virus.

Viral antibodies are typically composed of four polypeptide chains - two heavy chains and two light chains - that are held together by disulfide bonds. The binding site for the antigen is located at the tip of the Y-shaped structure, formed by the variable regions of the heavy and light chains.

There are five classes of antibodies in humans: IgA, IgD, IgE, IgG, and IgM. Each class has a different function and is distributed differently throughout the body. For example, IgG is the most common type of antibody found in the bloodstream and provides long-term immunity against viruses, while IgA is found primarily in mucous membranes and helps to protect against respiratory and gastrointestinal infections.

In addition to their role in the immune response, viral antibodies can also be used as diagnostic tools to detect the presence of a specific virus in a patient's blood or other bodily fluids.

Feces are the solid or semisolid remains of food that could not be digested or absorbed in the small intestine, along with bacteria and other waste products. After being stored in the colon, feces are eliminated from the body through the rectum and anus during defecation. Feces can vary in color, consistency, and odor depending on a person's diet, health status, and other factors.

Capsid proteins are the structural proteins that make up the capsid, which is the protective shell of a virus. The capsid encloses the viral genome and helps to protect it from degradation and detection by the host's immune system. Capsid proteins are typically arranged in a symmetrical pattern and can self-assemble into the capsid structure when exposed to the viral genome.

The specific arrangement and composition of capsid proteins vary between different types of viruses, and they play important roles in the virus's life cycle, including recognition and binding to host cells, entry into the cell, and release of the viral genome into the host cytoplasm. Capsid proteins can also serve as targets for antiviral therapies and vaccines.

Synthetic vaccines are artificially produced, designed to stimulate an immune response and provide protection against specific diseases. Unlike traditional vaccines that are derived from weakened or killed pathogens, synthetic vaccines are created using synthetic components, such as synthesized viral proteins, DNA, or RNA. These components mimic the disease-causing agent and trigger an immune response without causing the actual disease. The use of synthetic vaccines offers advantages in terms of safety, consistency, and scalability in production, making them valuable tools for preventing infectious diseases.

I could not find a specific medical definition for "Vaccines, DNA." However, I can provide you with some information about DNA vaccines.

DNA vaccines are a type of vaccine that uses genetically engineered DNA to stimulate an immune response in the body. They work by introducing a small piece of DNA into the body that contains the genetic code for a specific antigen (a substance that triggers an immune response). The cells of the body then use this DNA to produce the antigen, which prompts the immune system to recognize and attack it.

DNA vaccines have several advantages over traditional vaccines. They are relatively easy to produce, can be stored at room temperature, and can be designed to protect against a wide range of diseases. Additionally, because they use DNA to stimulate an immune response, DNA vaccines do not require the growth and culture of viruses or bacteria, which can make them safer than traditional vaccines.

DNA vaccines are still in the experimental stages, and more research is needed to determine their safety and effectiveness. However, they have shown promise in animal studies and are being investigated as a potential tool for preventing a variety of infectious diseases, including influenza, HIV, and cancer.

Immunization programs, also known as vaccination programs, are organized efforts to administer vaccines to populations or communities in order to protect individuals from vaccine-preventable diseases. These programs are typically implemented by public health agencies and involve the planning, coordination, and delivery of immunizations to ensure that a high percentage of people are protected against specific infectious diseases.

Immunization programs may target specific age groups, such as infants and young children, or populations at higher risk of certain diseases, such as travelers, healthcare workers, or individuals with weakened immune systems. The goals of immunization programs include controlling and eliminating vaccine-preventable diseases, reducing the morbidity and mortality associated with these diseases, and protecting vulnerable populations from outbreaks and epidemics.

Immunization programs may be delivered through a variety of settings, including healthcare facilities, schools, community centers, and mobile clinics. They often involve partnerships between government agencies, healthcare providers, non-governmental organizations, and communities to ensure that vaccines are accessible, affordable, and acceptable to the populations they serve. Effective immunization programs require strong leadership, adequate funding, robust data systems, and ongoing monitoring and evaluation to assess their impact and identify areas for improvement.

Safety-based drug withdrawals refer to the removal of a medication from the market due to concerns about its safety profile. This action is typically taken by regulatory authorities, such as the US Food and Drug Administration (FDA), when new information emerges that suggests a drug may pose an unacceptable risk of harm to patients, even if the benefit-risk balance was previously considered favorable.

Safety-based drug withdrawals can occur for various reasons, including the identification of new adverse effects, interactions with other medications or medical conditions, or an increased understanding of the drug's pharmacology or toxicology. In some cases, safety-based drug withdrawals may be temporary, allowing the manufacturer to conduct further studies and address the safety concerns. However, in other instances, the withdrawal may be permanent, leading to the discontinuation of the drug's production and distribution.

It is important to note that safety-based drug withdrawals are rare and typically represent a small fraction of the drugs approved for use. Nevertheless, they serve as an essential mechanism for protecting public health and ensuring that medications on the market are safe and effective for their intended use.

Bacterial vaccines are types of vaccines that are created using bacteria or parts of bacteria as the immunogen, which is the substance that triggers an immune response in the body. The purpose of a bacterial vaccine is to stimulate the immune system to develop protection against specific bacterial infections.

There are several types of bacterial vaccines, including:

1. Inactivated or killed whole-cell vaccines: These vaccines contain entire bacteria that have been killed or inactivated through various methods, such as heat or chemicals. The bacteria can no longer cause disease, but they still retain the ability to stimulate an immune response.
2. Subunit, protein, or polysaccharide vaccines: These vaccines use specific components of the bacterium, such as proteins or polysaccharides, that are known to trigger an immune response. By using only these components, the vaccine can avoid using the entire bacterium, which may reduce the risk of adverse reactions.
3. Live attenuated vaccines: These vaccines contain live bacteria that have been weakened or attenuated so that they cannot cause disease but still retain the ability to stimulate an immune response. This type of vaccine can provide long-lasting immunity, but it may not be suitable for people with weakened immune systems.

Bacterial vaccines are essential tools in preventing and controlling bacterial infections, reducing the burden of diseases such as tuberculosis, pneumococcal disease, meningococcal disease, and Haemophilus influenzae type b (Hib) disease. They work by exposing the immune system to a harmless form of the bacteria or its components, which triggers the production of antibodies and memory cells that can recognize and fight off future infections with that same bacterium.

It's important to note that while vaccines are generally safe and effective, they may cause mild side effects such as pain, redness, or swelling at the injection site, fever, or fatigue. Serious side effects are rare but can occur, so it's essential to consult with a healthcare provider before receiving any vaccine.

I'm sorry for any confusion, but "Nicaragua" is not a medical term. It is the largest country in the Central American Isthmus, bordering Honduras to the north and Costa Rica to the south. It has coastlines on both the Caribbean Sea and the North Pacific Ocean.

If you have any medical questions or terms you would like defined, I'd be happy to help!

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

An AIDS vaccine is a type of preventive vaccine that aims to stimulate the immune system to produce an effective response against the human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome (AIDS). The goal of an AIDS vaccine is to induce the production of immune cells and proteins that can recognize and eliminate HIV-infected cells, thereby preventing the establishment of a persistent infection.

Despite decades of research, there is still no licensed AIDS vaccine available. This is due in part to the unique challenges posed by HIV, which has a high mutation rate and can rapidly evolve to evade the immune system's defenses. However, several promising vaccine candidates are currently being tested in clinical trials around the world, and researchers continue to explore new approaches and strategies for developing an effective AIDS vaccine.

An antigen is any substance that can stimulate an immune response, particularly the production of antibodies. Viral antigens are antigens that are found on or produced by viruses. They can be proteins, glycoproteins, or carbohydrates present on the surface or inside the viral particle.

Viral antigens play a crucial role in the immune system's recognition and response to viral infections. When a virus infects a host cell, it may display its antigens on the surface of the infected cell. This allows the immune system to recognize and target the infected cells for destruction, thereby limiting the spread of the virus.

Viral antigens are also important targets for vaccines. Vaccines typically work by introducing a harmless form of a viral antigen to the body, which then stimulates the production of antibodies and memory T-cells that can recognize and respond quickly and effectively to future infections with the actual virus.

It's worth noting that different types of viruses have different antigens, and these antigens can vary between strains of the same virus. This is why there are often different vaccines available for different viral diseases, and why flu vaccines need to be updated every year to account for changes in the circulating influenza virus strains.

Program Evaluation is a systematic and objective assessment of a healthcare program's design, implementation, and outcomes. It is a medical term used to describe the process of determining the relevance, effectiveness, and efficiency of a program in achieving its goals and objectives. Program evaluation involves collecting and analyzing data related to various aspects of the program, such as its reach, impact, cost-effectiveness, and quality. The results of program evaluation can be used to improve the design and implementation of existing programs or to inform the development of new ones. It is a critical tool for ensuring that healthcare programs are meeting the needs of their intended audiences and delivering high-quality care in an efficient and effective manner.

Vaccine potency is a measure of the ability of a vaccine to induce an immune response in the recipient, typically measured by its ability to stimulate the production of antibodies or activate immune cells. It is usually expressed as the amount of antigen contained in the vaccine or the dose required to produce a specific level of immunity in a certain percentage of vaccinated individuals.

Potency testing is an important part of vaccine manufacturing and quality control, as it helps ensure that each batch of vaccine contains sufficient levels of active ingredients to provide protection against the targeted disease. Vaccine potency may be affected by various factors, including the age and health status of the recipient, the route of administration, and the storage and handling conditions of the vaccine.

Conjugate vaccines are a type of vaccine that combines a part of a bacterium with a protein or other substance to boost the body's immune response to the bacteria. The bacterial component is usually a polysaccharide, which is a long chain of sugars that makes up part of the bacterial cell wall.

By itself, a polysaccharide is not very immunogenic, meaning it does not stimulate a strong immune response. However, when it is conjugated or linked to a protein or other carrier molecule, it becomes much more immunogenic and can elicit a stronger and longer-lasting immune response.

Conjugate vaccines are particularly effective in protecting against bacterial infections that affect young children, such as Haemophilus influenzae type b (Hib) and pneumococcal disease. These vaccines have been instrumental in reducing the incidence of these diseases and their associated complications, such as meningitis and pneumonia.

Overall, conjugate vaccines work by mimicking a natural infection and stimulating the immune system to produce antibodies that can protect against future infections with the same bacterium. By combining a weakly immunogenic polysaccharide with a protein carrier, these vaccines can elicit a stronger and more effective immune response, providing long-lasting protection against bacterial infections.

A subunit vaccine is a type of vaccine that contains a specific piece or component of the microorganism (such as a protein, sugar, or part of the bacterial outer membrane), instead of containing the entire organism. This piece of the microorganism is known as an antigen, and it stimulates an immune response in the body, allowing the development of immunity against the targeted infection without introducing the risk of disease associated with live vaccines.

Subunit vaccines offer several advantages over other types of vaccines. They are generally safer because they do not contain live or weakened microorganisms, making them suitable for individuals with weakened immune systems or specific medical conditions that prevent them from receiving live vaccines. Additionally, subunit vaccines can be designed to focus on the most immunogenic components of a pathogen, potentially leading to stronger and more targeted immune responses.

Examples of subunit vaccines include the Hepatitis B vaccine, which contains a viral protein, and the Haemophilus influenzae type b (Hib) vaccine, which uses pieces of the bacterial polysaccharide capsule. These vaccines have been crucial in preventing serious infectious diseases and reducing associated complications worldwide.

Hospitalization is the process of admitting a patient to a hospital for the purpose of receiving medical treatment, surgery, or other health care services. It involves staying in the hospital as an inpatient, typically under the care of doctors, nurses, and other healthcare professionals. The length of stay can vary depending on the individual's medical condition and the type of treatment required. Hospitalization may be necessary for a variety of reasons, such as to receive intensive care, to undergo diagnostic tests or procedures, to recover from surgery, or to manage chronic illnesses or injuries.

Immunoglobulin A (IgA) is a type of antibody that plays a crucial role in the immune function of the human body. It is primarily found in external secretions, such as saliva, tears, breast milk, and sweat, as well as in mucous membranes lining the respiratory and gastrointestinal tracts. IgA exists in two forms: a monomeric form found in serum and a polymeric form found in secretions.

The primary function of IgA is to provide immune protection at mucosal surfaces, which are exposed to various environmental antigens, such as bacteria, viruses, parasites, and allergens. By doing so, it helps prevent the entry and colonization of pathogens into the body, reducing the risk of infections and inflammation.

IgA functions by binding to antigens present on the surface of pathogens or allergens, forming immune complexes that can neutralize their activity. These complexes are then transported across the epithelial cells lining mucosal surfaces and released into the lumen, where they prevent the adherence and invasion of pathogens.

In summary, Immunoglobulin A (IgA) is a vital antibody that provides immune defense at mucosal surfaces by neutralizing and preventing the entry of harmful antigens into the body.

I'm sorry for any confusion, but "Latin America" is not a medical term. It is a geographical and cultural region that includes parts of North America, Central America, South America, and the Caribbean where Romance languages (Spanish, Portuguese, and French) are predominantly spoken. The term does not have a specific medical relevance or definition.

Product surveillance, postmarketing refers to the ongoing monitoring and evaluation of a pharmaceutical or medical device product after it has been approved and released on the market. This process is used to detect any safety issues, adverse effects, or product performance concerns that may not have been identified during clinical trials. The data collected from postmarketing surveillance helps regulatory agencies, such as the U.S. Food and Drug Administration (FDA), to make informed decisions about the continued use, modification, or withdrawal of a product from the market. Postmarketing surveillance is an essential component of post-market risk management and helps ensure the safety and efficacy of medical products throughout their lifecycle.

The Diphtheria-Tetanus-Pertussis (DTaP) vaccine is a combination immunization that protects against three bacterial diseases: diphtheria, tetanus (lockjaw), and pertussis (whooping cough).

Diphtheria is an upper respiratory infection that can lead to breathing difficulties, heart failure, paralysis, or even death. Tetanus is a bacterial infection that affects the nervous system and causes muscle stiffness and spasms, leading to "lockjaw." Pertussis is a highly contagious respiratory infection characterized by severe coughing fits, which can make it difficult to breathe and may lead to pneumonia, seizures, or brain damage.

The DTaP vaccine contains inactivated toxins (toxoids) from the bacteria that cause these diseases. It is typically given as a series of five shots, with doses administered at 2 months, 4 months, 6 months, 15-18 months, and 4-6 years of age. The vaccine helps the immune system develop protection against the diseases without causing the actual illness.

It is important to note that there are other combination vaccines available that protect against these same diseases, such as DT (diphtheria and tetanus toxoids) and Tdap (tetanus, diphtheria, and acellular pertussis), which contain higher doses of the diphtheria and pertussis components. These vaccines are recommended for different age groups and may be used as booster shots to maintain immunity throughout adulthood.

Oral administration is a route of giving medications or other substances by mouth. This can be in the form of tablets, capsules, liquids, pastes, or other forms that can be swallowed. Once ingested, the substance is absorbed through the gastrointestinal tract and enters the bloodstream to reach its intended target site in the body. Oral administration is a common and convenient route of medication delivery, but it may not be appropriate for all substances or in certain situations, such as when rapid onset of action is required or when the patient has difficulty swallowing.

Developed countries, also known as high-income countries or industrialized nations, are sovereign states that have advanced economies and highly developed infrastructure. These countries typically have high levels of industrialization, urbanization, and technological development, along with a high standard of living and access to quality healthcare, education, and social services.

The World Bank defines developed countries as those with a gross national income (GNI) per capita of $12,695 or more in 2020. Examples of developed countries include the United States, Canada, Germany, France, Japan, Australia, and many others in Western Europe and Asia.

It's important to note that the term "developed" is relative and can change over time as a country's economy and infrastructure advance or decline. Additionally, there are significant disparities within developed countries, with some regions or populations experiencing poverty, inequality, and lack of access to basic needs and services.

Poliovirus Vaccine, Oral (OPV) is a vaccine used to prevent poliomyelitis (polio). It contains live attenuated (weakened) polioviruses, which stimulate an immune response in the body and provide protection against all three types of wild, infectious polioviruses. OPV is given by mouth, usually in drops, and it replicates in the gastrointestinal tract, where it induces a strong immune response. This response not only protects the individual who receives the vaccine but also helps to stop the spread of poliovirus in the community, providing indirect protection (herd immunity) to those who are not vaccinated. OPV is safe, effective, and easy to administer, making it an important tool for global polio eradication efforts. However, due to the risk of vaccine-associated paralytic polio (VAPP), inactivated poliovirus vaccine (IPV) is recommended for routine immunization in some countries.

I'm sorry for any confusion, but "United States" is a geopolitical entity, specifically the name of the country consisting of 50 states, and it is not a medical term or concept. Therefore, I can't provide a medical definition for it. If you have any questions related to health, medicine, or biology, I would be happy to try to help answer those!

Virus shedding refers to the release of virus particles by an infected individual, who can then transmit the virus to others through various means such as respiratory droplets, fecal matter, or bodily fluids. This occurs when the virus replicates inside the host's cells and is released into the surrounding environment, where it can infect other individuals. The duration of virus shedding varies depending on the specific virus and the individual's immune response. It's important to note that some individuals may shed viruses even before they show symptoms, making infection control measures such as hand hygiene, mask-wearing, and social distancing crucial in preventing the spread of infectious diseases.

Malaria vaccines are biological preparations that induce immunity against malaria parasites, thereby preventing or reducing the severity of malaria disease. They typically contain antigens (proteins or other molecules derived from the parasite) that stimulate an immune response in the recipient, enabling their body to recognize and neutralize the pathogen upon exposure.

The most advanced malaria vaccine candidate is RTS,S/AS01 (Mosquirix), which targets the Plasmodium falciparum parasite's circumsporozoite protein (CSP). This vaccine has shown partial protection in clinical trials, reducing the risk of severe malaria and hospitalization in young children by about 30% over four years. However, it does not provide complete immunity, and additional research is ongoing to develop more effective vaccines against malaria.

Serotyping is a laboratory technique used to classify microorganisms, such as bacteria and viruses, based on the specific antigens or proteins present on their surface. It involves treating the microorganism with different types of antibodies and observing which ones bind to its surface. Each distinct set of antigens corresponds to a specific serotype, allowing for precise identification and characterization of the microorganism. This technique is particularly useful in epidemiology, vaccine development, and infection control.

"Live unattenuated vaccines" are a type of vaccine that contains live, weakened (not dead) microorganisms, such as bacteria or viruses. The weakened microorganisms in the vaccine are still alive, but they have been altered to reduce or eliminate their ability to cause disease. They are also called "live attenuated vaccines."

The purpose of using live, weakened microorganisms in a vaccine is to stimulate a strong and long-lasting immune response in the body. When the weakened microorganisms are introduced into the body through vaccination, they are able to multiply and cause an infection that is mild enough for the immune system to fight off without causing the disease. This process helps the immune system to recognize and remember the microorganism, so that it can mount a rapid and effective response if it encounters the same microorganism again in the future.

Examples of live unattenuated vaccines include the measles, mumps, and rubella (MMR) vaccine, the chickenpox (varicella) vaccine, and the oral poliovirus vaccine. These vaccines are highly effective at preventing the diseases they target, but they may not be suitable for people with weakened immune systems or certain other health conditions. It is important to consult with a healthcare provider before receiving any type of vaccine to ensure that it is safe and appropriate.

Papillomavirus vaccines are vaccines that have been developed to prevent infection by human papillomaviruses (HPV). HPV is a DNA virus that is capable of infecting the skin and mucous membranes. Certain types of HPV are known to cause cervical cancer, as well as other types of cancer such as anal, penile, vulvar, and oropharyngeal cancers. Other types of HPV can cause genital warts.

There are currently two papillomavirus vaccines that have been approved for use in the United States: Gardasil and Cervarix. Both vaccines protect against the two most common cancer-causing types of HPV (types 16 and 18), which together cause about 70% of cervical cancers. Gardasil also protects against the two most common types of HPV that cause genital warts (types 6 and 11).

Papillomavirus vaccines are given as a series of three shots over a period of six months. They are most effective when given to people before they become sexually active, as this reduces the risk of exposure to HPV. The Centers for Disease Control and Prevention (CDC) recommends that all boys and girls get vaccinated against HPV at age 11 or 12, but the vaccine can be given to people as young as age 9 and as old as age 26.

It is important to note that papillomavirus vaccines do not protect against all types of HPV, and they do not treat existing HPV infections or cervical cancer. They are intended to prevent new HPV infections and the cancers and other diseases that can be caused by HPV.

Neutralization tests are a type of laboratory assay used in microbiology and immunology to measure the ability of a substance, such as an antibody or antitoxin, to neutralize the activity of a toxin or infectious agent. In these tests, the substance to be tested is mixed with a known quantity of the toxin or infectious agent, and the mixture is then incubated under controlled conditions. After incubation, the mixture is tested for residual toxicity or infectivity using a variety of methods, such as cell culture assays, animal models, or biochemical assays.

The neutralization titer is then calculated based on the highest dilution of the test substance that completely neutralizes the toxin or infectious agent. Neutralization tests are commonly used in the diagnosis and evaluation of immune responses to vaccines, as well as in the detection and quantification of toxins and other harmful substances.

Examples of neutralization tests include the serum neutralization test for measles antibodies, the plaque reduction neutralization test (PRNT) for dengue virus antibodies, and the cytotoxicity neutralization assay for botulinum neurotoxins.

Secondary immunization, also known as "anamnestic response" or "booster," refers to the enhanced immune response that occurs upon re-exposure to an antigen, having previously been immunized or infected with the same pathogen. This response is characterized by a more rapid and robust production of antibodies and memory cells compared to the primary immune response. The secondary immunization aims to maintain long-term immunity against infectious diseases and improve vaccine effectiveness. It usually involves administering additional doses of a vaccine or booster shots after the initial series of immunizations, which helps reinforce the immune system's ability to recognize and combat specific pathogens.

I'm sorry for any confusion, but "seasons" is not a term that has a medical definition. Seasons refer to the four divisions of the year (spring, summer, autumn or fall, and winter) based on the position of the earth in its orbit around the sun. If you have any questions related to health or medicine, I'd be happy to try to help answer those!

A germ-free life refers to an existence in which an individual is not exposed to or colonized by any harmful microorganisms, such as bacteria, viruses, fungi, or parasites. This condition is also known as "sterile" or "aseptic." In a medical context, achieving a germ-free state is often the goal in certain controlled environments, such as operating rooms, laboratories, and intensive care units, where the risk of infection must be minimized. However, it is not possible to maintain a completely germ-free life outside of these settings, as microorganisms are ubiquitous in the environment and are an essential part of the human microbiome. Instead, maintaining good hygiene practices and a healthy immune system is crucial for preventing illness and promoting overall health.

The term "developing countries" is a socio-economic classification used to describe nations that are in the process of industrialization and modernization. This term is often used interchangeably with "low and middle-income countries" or "Global South." The World Bank defines developing countries as those with a gross national income (GNI) per capita of less than US $12,695.

In the context of healthcare, developing countries face unique challenges including limited access to quality medical care, lack of resources and infrastructure, high burden of infectious diseases, and a shortage of trained healthcare professionals. These factors contribute to significant disparities in health outcomes between developing and developed nations.

I'm sorry for any confusion, but "Uzbekistan" is not a medical term. It is the name of a country located in Central Asia. If you have any questions related to medical terminology or health-related topics, I would be happy to try and help answer those for you.

Meningococcal vaccines are vaccines that protect against Neisseria meningitidis, a type of bacteria that can cause serious infections such as meningitis (inflammation of the lining of the brain and spinal cord) and septicemia (bloodstream infection). There are several types of meningococcal vaccines available, including conjugate vaccines and polysaccharide vaccines. These vaccines work by stimulating the immune system to produce antibodies that can protect against the different serogroups of N. meningitidis, including A, B, C, Y, and W-135. The specific type of vaccine used and the number of doses required may depend on a person's age, health status, and other factors. Meningococcal vaccines are recommended for certain high-risk populations, such as infants, young children, adolescents, and people with certain medical conditions, as well as for travelers to areas where meningococcal disease is common.

Cost-benefit analysis (CBA) is a systematic process used to compare the costs and benefits of different options to determine which one provides the greatest net benefit. In a medical context, CBA can be used to evaluate the value of medical interventions, treatments, or policies by estimating and monetizing all the relevant costs and benefits associated with each option.

The costs included in a CBA may include direct costs such as the cost of the intervention or treatment itself, as well as indirect costs such as lost productivity or time away from work. Benefits may include improved health outcomes, reduced morbidity or mortality, and increased quality of life.

Once all the relevant costs and benefits have been identified and quantified, they are typically expressed in monetary terms to allow for a direct comparison. The option with the highest net benefit (i.e., the difference between total benefits and total costs) is considered the most cost-effective.

It's important to note that CBA has some limitations and can be subject to various biases and assumptions, so it should be used in conjunction with other evaluation methods to ensure a comprehensive understanding of the value of medical interventions or policies.

"Hepatitis B vaccines are vaccines that prevent infection caused by the hepatitis B virus. They work by introducing a small and harmless piece of the virus to your body, which triggers your immune system to produce antibodies to fight off the infection. These antibodies remain in your body and provide protection if you are exposed to the real hepatitis B virus in the future.

The hepatitis B vaccine is typically given as a series of three shots over a six-month period. It is recommended for all infants, children and adolescents who have not previously been vaccinated, as well as for adults who are at increased risk of infection, such as healthcare workers, people who inject drugs, and those with certain medical conditions.

It's important to note that hepatitis B vaccine does not provide protection against other types of viral hepatitis, such as hepatitis A or C."

Immunization is defined medically as the process where an individual is made immune or resistant to an infectious disease, typically through the administration of a vaccine. The vaccine stimulates the body's own immune system to recognize and fight off the specific disease-causing organism, thereby preventing or reducing the severity of future infections with that organism.

Immunization can be achieved actively, where the person is given a vaccine to trigger an immune response, or passively, where antibodies are transferred to the person through immunoglobulin therapy. Immunizations are an important part of preventive healthcare and have been successful in controlling and eliminating many infectious diseases worldwide.

I'm sorry for any confusion, but "Mexico" is not a medical term or concept. It is the name of a country located in North America. If you have any questions related to medical topics, I would be happy to try and help answer those for you.

A measles vaccine is a biological preparation that induces immunity against the measles virus. It contains an attenuated (weakened) strain of the measles virus, which stimulates the immune system to produce antibodies that protect against future infection with the wild-type (disease-causing) virus. Measles vaccines are typically administered in combination with vaccines against mumps and rubella (German measles), forming the MMR vaccine.

The measles vaccine is highly effective, with one or two doses providing immunity in over 95% of people who receive it. It is usually given to children as part of routine childhood immunization programs, with the first dose administered at 12-15 months of age and the second dose at 4-6 years of age.

Measles vaccination has led to a dramatic reduction in the incidence of measles worldwide and is considered one of the greatest public health achievements of the past century. However, despite widespread availability of the vaccine, measles remains a significant cause of morbidity and mortality in some parts of the world, particularly in areas with low vaccination coverage or where access to healthcare is limited.

Clinical trials are research studies that involve human participants and are designed to evaluate the safety and efficacy of new medical treatments, drugs, devices, or behavioral interventions. The purpose of clinical trials is to determine whether a new intervention is safe, effective, and beneficial for patients, as well as to compare it with currently available treatments. Clinical trials follow a series of phases, each with specific goals and criteria, before a new intervention can be approved by regulatory authorities for widespread use.

Clinical trials are conducted according to a protocol, which is a detailed plan that outlines the study's objectives, design, methodology, statistical analysis, and ethical considerations. The protocol is developed and reviewed by a team of medical experts, statisticians, and ethicists, and it must be approved by an institutional review board (IRB) before the trial can begin.

Participation in clinical trials is voluntary, and participants must provide informed consent before enrolling in the study. Informed consent involves providing potential participants with detailed information about the study's purpose, procedures, risks, benefits, and alternatives, as well as their rights as research subjects. Participants can withdraw from the study at any time without penalty or loss of benefits to which they are entitled.

Clinical trials are essential for advancing medical knowledge and improving patient care. They help researchers identify new treatments, diagnostic tools, and prevention strategies that can benefit patients and improve public health. However, clinical trials also pose potential risks to participants, including adverse effects from experimental interventions, time commitment, and inconvenience. Therefore, it is important for researchers to carefully design and conduct clinical trials to minimize risks and ensure that the benefits outweigh the risks.

In epidemiology, the incidence of a disease is defined as the number of new cases of that disease within a specific population over a certain period of time. It is typically expressed as a rate, with the number of new cases in the numerator and the size of the population at risk in the denominator. Incidence provides information about the risk of developing a disease during a given time period and can be used to compare disease rates between different populations or to monitor trends in disease occurrence over time.

Genotype, in genetics, refers to the complete heritable genetic makeup of an individual organism, including all of its genes. It is the set of instructions contained in an organism's DNA for the development and function of that organism. The genotype is the basis for an individual's inherited traits, and it can be contrasted with an individual's phenotype, which refers to the observable physical or biochemical characteristics of an organism that result from the expression of its genes in combination with environmental influences.

It is important to note that an individual's genotype is not necessarily identical to their genetic sequence. Some genes have multiple forms called alleles, and an individual may inherit different alleles for a given gene from each parent. The combination of alleles that an individual inherits for a particular gene is known as their genotype for that gene.

Understanding an individual's genotype can provide important information about their susceptibility to certain diseases, their response to drugs and other treatments, and their risk of passing on inherited genetic disorders to their offspring.

I'm sorry for any confusion, but "Program Development" is not a medical term. It is a general term that refers to the process of creating, planning, and implementing a new program or project, typically in a business, education, or community setting. In a healthcare context, it might refer to the development of a new healthcare service, treatment program, or educational initiative.

If you have any questions related to medical terminology or concepts, I'd be happy to try and help!

A Pertussis vaccine is a type of immunization used to protect against pertussis, also known as whooping cough. It contains components that stimulate the immune system to produce antibodies against the bacteria that cause pertussis, Bordetella pertussis. There are two main types of pertussis vaccines: whole-cell pertussis (wP) vaccines and acellular pertussis (aP) vaccines. wP vaccines contain killed whole cells of B. pertussis, while aP vaccines contain specific components of the bacteria, such as pertussis toxin and other antigens. Pertussis vaccines are often combined with diphtheria and tetanus to form combination vaccines, such as DTaP (diphtheria, tetanus, and acellular pertussis) and TdaP (tetanus, diphtheria, and acellular pertussis). These vaccines are typically given to young children as part of their routine immunization schedule.

I'm sorry for any confusion, but "Philadelphia" is not a medical term. It is a place name, specifically referring to a large city in the state of Pennsylvania, USA. However, it could be used in a medical context if someone were discussing a treatment or procedure that was first developed or primarily practiced in Philadelphia.

If you're looking for a medical term, I'd be happy to help. Could you please provide more details?

A pediatric hospital is a specialized medical facility that provides comprehensive healthcare services for infants, children, adolescents, and young adults up to the age of 21. These hospitals employ medical professionals with expertise in treating various childhood illnesses, injuries, and developmental disorders. The facilities are designed to cater to the unique needs of children, including child-friendly environments, specialized equipment, and age-appropriate care.

Pediatric hospitals offer a wide range of services such as inpatient and outpatient care, emergency services, surgical procedures, diagnostic testing, rehabilitation, and mental health services. They also focus on preventive healthcare, family-centered care, and education to support the overall well-being of their young patients. Some pediatric hospitals may specialize further, focusing on specific areas such as cancer treatment, cardiology, neurology, or orthopedics.

Haemophilus vaccines are vaccines that are designed to protect against Haemophilus influenzae type b (Hib), a bacterium that can cause serious infections such as meningitis, pneumonia, and epiglottitis. There are two main types of Hib vaccines:

1. Polysaccharide vaccine: This type of vaccine is made from the sugar coating (polysaccharide) of the bacterial cells. It is not effective in children under 2 years of age because their immune systems are not yet mature enough to respond effectively to this type of vaccine.
2. Conjugate vaccine: This type of vaccine combines the polysaccharide with a protein carrier, which helps to stimulate a stronger and more sustained immune response. It is effective in infants as young as 6 weeks old.

Hib vaccines are usually given as part of routine childhood immunizations starting at 2 months of age. They are administered through an injection into the muscle. The vaccine is safe and effective, with few side effects. Vaccination against Hib has led to a significant reduction in the incidence of Hib infections worldwide.

An Enzyme-Linked Immunosorbent Assay (ELISA) is a type of analytical biochemistry assay used to detect and quantify the presence of a substance, typically a protein or peptide, in a liquid sample. It takes its name from the enzyme-linked antibodies used in the assay.

In an ELISA, the sample is added to a well containing a surface that has been treated to capture the target substance. If the target substance is present in the sample, it will bind to the surface. Next, an enzyme-linked antibody specific to the target substance is added. This antibody will bind to the captured target substance if it is present. After washing away any unbound material, a substrate for the enzyme is added. If the enzyme is present due to its linkage to the antibody, it will catalyze a reaction that produces a detectable signal, such as a color change or fluorescence. The intensity of this signal is proportional to the amount of target substance present in the sample, allowing for quantification.

ELISAs are widely used in research and clinical settings to detect and measure various substances, including hormones, viruses, and bacteria. They offer high sensitivity, specificity, and reproducibility, making them a reliable choice for many applications.

BCG (Bacillus Calmette-Guérin) vaccine is a type of immunization used primarily to prevent tuberculosis (TB). It contains a live but weakened strain of Mycobacterium bovis, which is related to the bacterium that causes TB in humans (Mycobacterium tuberculosis).

The BCG vaccine works by stimulating an immune response in the body, enabling it to better resist infection with TB bacteria if exposed in the future. It is often given to infants and children in countries where TB is common, and its use varies depending on the national immunization policies. The protection offered by the BCG vaccine is moderate and may not last for a very long time.

In addition to its use against TB, the BCG vaccine has also been investigated for its potential therapeutic role in treating bladder cancer and some other types of cancer. The mechanism of action in these cases is thought to be related to the vaccine's ability to stimulate an immune response against abnormal cells.

Rabies vaccines are medical products that contain antigens of the rabies virus, which stimulate an immune response in individuals who receive them. The purpose of rabies vaccines is to prevent the development of rabies, a viral disease that is almost always fatal once symptoms appear.

There are two primary types of rabies vaccines available:

1. Pre-exposure prophylaxis (PrEP) vaccines: These vaccines are given to individuals who are at high risk of coming into contact with the rabies virus, such as veterinarians, animal handlers, and travelers visiting areas where rabies is common. The vaccine series typically consists of three doses given over a period of 28 days.
2. Post-exposure prophylaxis (PEP) vaccines: These vaccines are administered to individuals who have already been exposed to the rabies virus, usually through a bite or scratch from an infected animal. The vaccine series typically consists of four doses given over a period of 14 days, along with a dose of rabies immune globulin (RIG) to provide immediate protection while the immune system responds to the vaccine.

Both types of rabies vaccines are highly effective at preventing the disease, but it is essential to receive them as soon as possible after exposure or before potential exposure, as the virus can be fatal if left untreated.

Poliovirus Vaccine, Inactivated (IPV) is a vaccine used to prevent poliomyelitis (polio), a highly infectious disease caused by the poliovirus. IPV contains inactivated (killed) polioviruses of all three poliovirus types. It works by stimulating an immune response in the body, but because the viruses are inactivated, they cannot cause polio. After vaccination, the immune system recognizes and responds to the inactivated viruses, producing antibodies that protect against future infection with wild, or naturally occurring, polioviruses. IPV is typically given as an injection in the leg or arm, and a series of doses are required for full protection. It is a safe and effective way to prevent polio and its complications.

Adverse Drug Reaction (ADR) Reporting Systems are spontaneous reporting systems used for monitoring the safety of authorized medicines in clinical practice. These systems collect and manage reports of suspected adverse drug reactions from healthcare professionals, patients, and pharmaceutical companies. The primary objective of ADR reporting systems is to identify new risks or previously unrecognized risks associated with the use of a medication, monitor the frequency and severity of known adverse effects, and contribute to post-marketing surveillance and pharmacovigilance activities.

Healthcare professionals, including physicians, pharmacists, and nurses, are encouraged to voluntarily report any suspected adverse drug reactions they encounter during their practice. In some countries, patients can also directly report any suspected adverse reactions they experience after taking a medication. Pharmaceutical companies are obligated to submit reports of adverse events identified through their own pharmacovigilance activities or from post-marketing surveillance studies.

The data collected through ADR reporting systems are analyzed to identify signals, which are defined as new, changing, or unknown safety concerns related to a medicine or vaccine. Signals are further investigated and evaluated for causality and clinical significance. If a signal is confirmed, regulatory actions may be taken, such as updating the product label, issuing safety communications, or restricting the use of the medication.

Examples of ADR reporting systems include the US Food and Drug Administration's (FDA) Adverse Event Reporting System (FAERS), the European Medicines Agency's (EMA) EudraVigilance, and the World Health Organization's (WHO) Uppsala Monitoring Centre.

I'm sorry for any confusion, but "India" is not a medical term or concept. It is a country in South Asia, the second-most populous country in the world, known for its rich history, diverse culture, and numerous contributions to various fields including medicine. If you have any questions related to medical topics, I would be happy to help answer them!

Cholera vaccines are preventive measures used to protect against the infection caused by the bacterium Vibrio cholerae. There are several types of cholera vaccines available, including:

1. Inactivated oral vaccine (ICCV): This vaccine contains killed whole-cell bacteria and is given in two doses, with each dose administered at least 14 days apart. It provides protection for up to six months and can be given to adults and children over the age of one year.
2. Live attenuated oral vaccine (LCV): This vaccine contains weakened live bacteria that are unable to cause disease but still stimulate an immune response. The most commonly used LCV is called CVD 103-HgR, which is given in a single dose and provides protection for up to three months. It can be given to adults and children over the age of six years.
3. Injectable cholera vaccine: This vaccine contains inactivated bacteria and is given as an injection. It is not widely available and its effectiveness is limited compared to oral vaccines.

Cholera vaccines are recommended for travelers visiting areas with known cholera outbreaks, particularly if they plan to eat food or drink water that may be contaminated. They can also be used in response to outbreaks to help control the spread of the disease. However, it is important to note that vaccination alone is not sufficient to prevent cholera infection and good hygiene practices, such as handwashing and safe food handling, should always be followed.

The double-blind method is a study design commonly used in research, including clinical trials, to minimize bias and ensure the objectivity of results. In this approach, both the participants and the researchers are unaware of which group the participants are assigned to, whether it be the experimental group or the control group. This means that neither the participants nor the researchers know who is receiving a particular treatment or placebo, thus reducing the potential for bias in the evaluation of outcomes. The assignment of participants to groups is typically done by a third party not involved in the study, and the codes are only revealed after all data have been collected and analyzed.

Immunoglobulin G (IgG) is a type of antibody, which is a protective protein produced by the immune system in response to foreign substances like bacteria or viruses. IgG is the most abundant type of antibody in human blood, making up about 75-80% of all antibodies. It is found in all body fluids and plays a crucial role in fighting infections caused by bacteria, viruses, and toxins.

IgG has several important functions:

1. Neutralization: IgG can bind to the surface of bacteria or viruses, preventing them from attaching to and infecting human cells.
2. Opsonization: IgG coats the surface of pathogens, making them more recognizable and easier for immune cells like neutrophils and macrophages to phagocytose (engulf and destroy) them.
3. Complement activation: IgG can activate the complement system, a group of proteins that work together to help eliminate pathogens from the body. Activation of the complement system leads to the formation of the membrane attack complex, which creates holes in the cell membranes of bacteria, leading to their lysis (destruction).
4. Antibody-dependent cellular cytotoxicity (ADCC): IgG can bind to immune cells like natural killer (NK) cells and trigger them to release substances that cause target cells (such as virus-infected or cancerous cells) to undergo apoptosis (programmed cell death).
5. Immune complex formation: IgG can form immune complexes with antigens, which can then be removed from the body through various mechanisms, such as phagocytosis by immune cells or excretion in urine.

IgG is a critical component of adaptive immunity and provides long-lasting protection against reinfection with many pathogens. It has four subclasses (IgG1, IgG2, IgG3, and IgG4) that differ in their structure, function, and distribution in the body.

Biological toxins are poisonous substances that are produced by living organisms such as bacteria, plants, and animals. They can cause harm to humans, animals, or the environment. Biological toxins can be classified into different categories based on their mode of action, such as neurotoxins (affecting the nervous system), cytotoxins (damaging cells), and enterotoxins (causing intestinal damage).

Examples of biological toxins include botulinum toxin produced by Clostridium botulinum bacteria, tetanus toxin produced by Clostridium tetani bacteria, ricin toxin from the castor bean plant, and saxitoxin produced by certain types of marine algae.

Biological toxins can cause a range of symptoms depending on the type and amount of toxin ingested or exposed to, as well as the route of exposure (e.g., inhalation, ingestion, skin contact). They can cause illnesses ranging from mild to severe, and some can be fatal if not treated promptly and effectively.

Prevention and control measures for biological toxins include good hygiene practices, vaccination against certain toxin-producing bacteria, avoidance of contaminated food or water sources, and personal protective equipment (PPE) when handling or working with potential sources of toxins.

The Smallpox vaccine is not a live virus vaccine but is instead made from a vaccinia virus, which is a virus related to the variola virus (the virus that causes smallpox). The vaccinia virus used in the vaccine does not cause smallpox, but it does cause a milder illness with symptoms such as a fever and a rash of pustules or blisters at the site of inoculation.

The smallpox vaccine was first developed by Edward Jenner in 1796 and is one of the oldest vaccines still in use today. It has been highly effective in preventing smallpox, which was once a major cause of death and disability worldwide. In fact, smallpox was declared eradicated by the World Health Organization (WHO) in 1980, thanks in large part to the widespread use of the smallpox vaccine.

Despite the eradication of smallpox, the smallpox vaccine is still used today in certain circumstances. For example, it may be given to laboratory workers who handle the virus or to military personnel who may be at risk of exposure to the virus. The vaccine may also be used as an emergency measure in the event of a bioterrorism attack involving smallpox.

It is important to note that the smallpox vaccine is not without risks and can cause serious side effects, including a severe allergic reaction (anaphylaxis), encephalitis (inflammation of the brain), and myocarditis (inflammation of the heart muscle). As a result, it is only given to people who are at high risk of exposure to the virus and who have been determined to be good candidates for vaccination by a healthcare professional.

I'm sorry for any confusion, but "Malawi" is not a medical term. It is the name of a country located in southeastern Africa. If you have any questions about medical terminology or health-related topics, I would be happy to help with those!

Typhoid-Paratyphoid vaccines are immunizations that protect against typhoid fever and paratyphoid fevers, which are caused by the Salmonella enterica serovars Typhi and Paratyphi, respectively. These vaccines contain inactivated or attenuated bacteria or specific antigens that stimulate an individual's immune system to develop immunity against these diseases without causing the illness itself. There are several types of typhoid-paratyphoid vaccines available, including:

1. Ty21a (oral live attenuated vaccine): This is a live but weakened form of the Salmonella Typhi bacteria. It is given orally in capsule form and requires a series of 4 doses taken every other day. The vaccine provides protection for about 5-7 years.
2. Vi polysaccharide (ViPS) typhoid vaccine: This vaccine contains purified Vi antigens from the Salmonella Typhi bacterium's outer capsular layer. It is given as an injection and provides protection for approximately 2-3 years.
3. Combined typhoid-paratyphoid A and B vaccines (Vi-rEPA): This vaccine combines Vi polysaccharide antigens from Salmonella Typhi and Paratyphi A and B. It is given as an injection and provides protection for about 3 years against typhoid fever and paratyphoid fevers A and B.
4. Typhoid conjugate vaccines (TCVs): These vaccines combine the Vi polysaccharide antigen from Salmonella Typhi with a protein carrier to enhance the immune response, particularly in children under 2 years of age. TCVs are given as an injection and provide long-lasting protection against typhoid fever.

It is important to note that none of these vaccines provides 100% protection, but they significantly reduce the risk of contracting typhoid or paratyphoid fevers. Additionally, good hygiene practices, such as handwashing and safe food handling, can further minimize the risk of infection.

A capsid is the protein shell that encloses and protects the genetic material of a virus. It is composed of multiple copies of one or more proteins that are arranged in a specific structure, which can vary in shape and symmetry depending on the type of virus. The capsid plays a crucial role in the viral life cycle, including protecting the viral genome from host cell defenses, mediating attachment to and entry into host cells, and assisting with the assembly of new virus particles during replication.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

"Cost of Illness" is a medical-economic concept that refers to the total societal cost associated with a specific disease or health condition. It includes both direct and indirect costs. Direct costs are those that can be directly attributed to the illness, such as medical expenses for diagnosis, treatment, rehabilitation, and medications. Indirect costs include productivity losses due to morbidity (reduced efficiency while working) and mortality (lost earnings due to death). Other indirect costs may encompass expenses related to caregiving or special education needs. The Cost of Illness is often used in health policy decision-making, resource allocation, and evaluating the economic impact of diseases on society.

The World Health Organization (WHO) is not a medical condition or term, but rather a specialized agency of the United Nations responsible for international public health. Here's a brief description:

The World Health Organization (WHO) is a specialized agency of the United Nations that acts as the global authority on public health issues. Established in 1948, WHO's primary role is to coordinate and collaborate with its member states to promote health, prevent diseases, and ensure universal access to healthcare services. WHO is headquartered in Geneva, Switzerland, and has regional offices around the world. It plays a crucial role in setting global health standards, monitoring disease outbreaks, and providing guidance on various public health concerns, including infectious diseases, non-communicable diseases, mental health, environmental health, and maternal, newborn, child, and adolescent health.

The chickenpox vaccine, also known as varicella vaccine, is a preventive measure against the highly contagious viral infection caused by the varicella-zoster virus. The vaccine contains a live but weakened form of the virus, which stimulates the immune system to produce a response without causing the disease itself.

The chickenpox vaccine is typically given in two doses, with the first dose administered between 12 and 15 months of age and the second dose between 4 and 6 years of age. In some cases, the vaccine may be given to older children, adolescents, or adults who have not previously been vaccinated or who have never had chickenpox.

The chickenpox vaccine is highly effective at preventing severe cases of the disease and reducing the risk of complications such as bacterial infections, pneumonia, and encephalitis. It is also effective at preventing transmission of the virus to others.

Like any vaccine, the chickenpox vaccine can cause mild side effects such as soreness at the injection site, fever, or a mild rash. However, these side effects are generally mild and short-lived. Serious side effects are rare but may include allergic reactions or severe immune responses.

Overall, the chickenpox vaccine is a safe and effective way to prevent this common childhood disease and its potential complications.

A placebo is a substance or treatment that has no inherent therapeutic effect. It is often used in clinical trials as a control against which the effects of a new drug or therapy can be compared. Placebos are typically made to resemble the active treatment, such as a sugar pill for a medication trial, so that participants cannot tell the difference between what they are receiving and the actual treatment.

The placebo effect refers to the phenomenon where patients experience real improvements in their symptoms or conditions even when given a placebo. This may be due to psychological factors such as belief in the effectiveness of the treatment, suggestion, or conditioning. The placebo effect is often used as a comparison group in clinical trials to help determine if the active treatment has a greater effect than no treatment at all.

A tuberculosis vaccine, also known as the BCG (Bacillus Calmette-Guérin) vaccine, is a type of immunization used to prevent tuberculosis (TB), a bacterial infection caused by Mycobacterium tuberculosis. The BCG vaccine contains a weakened strain of the bacteria that causes TB in cattle.

The BCG vaccine works by stimulating an immune response in the body, which helps to protect against severe forms of TB, such as TB meningitis and TB in children. However, it is not very effective at preventing pulmonary TB (TB that affects the lungs) in adults.

The BCG vaccine is not routinely recommended for use in the United States due to the low risk of TB infection in the general population. However, it may be given to people who are at high risk of exposure to TB, such as healthcare workers, laboratory personnel, and people traveling to countries with high rates of TB.

It is important to note that the BCG vaccine does not provide complete protection against TB and that other measures, such as testing and treatment for latent TB infection, are also important for controlling the spread of this disease.

Population surveillance in a public health and medical context refers to the ongoing, systematic collection, analysis, interpretation, and dissemination of health-related data for a defined population over time. It aims to monitor the health status, identify emerging health threats or trends, and evaluate the impact of interventions within that population. This information is used to inform public health policy, prioritize healthcare resources, and guide disease prevention and control efforts. Population surveillance can involve various data sources, such as vital records, disease registries, surveys, and electronic health records.

"Cattle" is a term used in the agricultural and veterinary fields to refer to domesticated animals of the genus *Bos*, primarily *Bos taurus* (European cattle) and *Bos indicus* (Zebu). These animals are often raised for meat, milk, leather, and labor. They are also known as bovines or cows (for females), bulls (intact males), and steers/bullocks (castrated males). However, in a strict medical definition, "cattle" does not apply to humans or other animals.

Immunologic adjuvants are substances that are added to a vaccine to enhance the body's immune response to the antigens contained in the vaccine. They work by stimulating the immune system and promoting the production of antibodies and activating immune cells, such as T-cells and macrophages, which help to provide a stronger and more sustained immune response to the vaccine.

Immunologic adjuvants can be derived from various sources, including bacteria, viruses, and chemicals. Some common examples include aluminum salts (alum), oil-in-water emulsions (such as MF59), and bacterial components (such as lipopolysaccharide or LPS).

The use of immunologic adjuvants in vaccines can help to improve the efficacy of the vaccine, particularly for vaccines that contain weak or poorly immunogenic antigens. They can also help to reduce the amount of antigen needed in a vaccine, which can be beneficial for vaccines that are difficult or expensive to produce.

It's important to note that while adjuvants can enhance the immune response to a vaccine, they can also increase the risk of adverse reactions, such as inflammation and pain at the injection site. Therefore, the use of immunologic adjuvants must be carefully balanced against their potential benefits and risks.

Poliomyelitis, also known as polio, is a highly infectious disease caused by a virus that invades the body through the mouth, usually from contaminated water or food. The virus multiplies in the intestine and can invade the nervous system, causing paralysis.

The medical definition of Poliomyelitis includes:

1. An acute viral infection caused by the poliovirus.
2. Characterized by inflammation of the gray matter of the spinal cord (poliomyelitis), leading to muscle weakness, and in some cases, paralysis.
3. The disease primarily affects children under 5 years of age.
4. Transmission occurs through the fecal-oral route or, less frequently, by respiratory droplets.
5. The virus enters the body via the mouth, multiplies in the intestines, and can invade the nervous system.
6. There are three types of poliovirus (types 1, 2, and 3), each capable of causing paralytic polio.
7. Infection with one type does not provide immunity to the other two types.
8. The disease has no cure, but vaccination can prevent it.
9. Two types of vaccines are available: inactivated poliovirus vaccine (IPV) and oral poliovirus vaccine (OPV).
10. Rare complications of OPV include vaccine-associated paralytic polio (VAPP) and circulating vaccine-derived polioviruses (cVDPVs).

The Mumps Vaccine is a biological preparation intended to induce immunity against mumps, a contagious viral infection that primarily affects the salivary glands. The vaccine contains live attenuated (weakened) mumps virus, which stimulates the immune system to develop a protective response without causing the disease.

There are two types of mumps vaccines available:

1. The Jeryl Lynn strain is used in the United States and is part of the Measles, Mumps, and Rubella (MMR) vaccine and the Measles, Mumps, Rubella, and Varicella (MMRV) vaccine. This strain is derived from a clinical isolate obtained from the throat washings of a child with mumps in 1963.
2. The Urabe AM9 strain was used in some countries but has been discontinued in many places due to an increased risk of meningitis as a rare complication.

The MMR vaccine is typically given to children at 12-15 months of age and again at 4-6 years of age, providing long-lasting immunity against mumps in most individuals. The vaccine has significantly reduced the incidence of mumps and its complications worldwide.

Hepatitis A vaccines are inactivated or live attenuated viral vaccines that are administered to prevent infection and illness caused by the hepatitis A virus. The vaccine contains antigens that stimulate an immune response in the body, leading to the production of antibodies that protect against future infection with the virus.

The inactivated hepatitis A vaccine is made from viruses that have been chemically treated to destroy their ability to cause disease while preserving their ability to stimulate an immune response. This type of vaccine is typically given in two doses, six months apart, and provides long-term protection against the virus.

The live attenuated hepatitis A vaccine contains a weakened form of the virus that is unable to cause illness but can still stimulate an immune response. This type of vaccine is given as a single dose and provides protection against the virus for at least 20 years.

Hepatitis A vaccines are recommended for people who are at increased risk of infection, including travelers to areas where hepatitis A is common, men who have sex with men, people who use injection drugs, and people with chronic liver disease or clotting factor disorders. The vaccine is also recommended for children in certain states and communities where hepatitis A is endemic.

I apologize, but "Brazil" is not a medical term or condition. It is the largest country in both South America and Latin America by land area and population. If you have any questions related to medical terminology or health concerns, please provide more information and I will do my best to help.

I apologize for any confusion, but "Asia" is not a medical term. It is the largest continent in the world, comprising about 30% of the Earth's total land area and containing around 60% of the world's current human population. It is divided into several regions, including Northern Asia (Siberia), Eastern Asia (China, Japan, Korea, Mongolia, Taiwan), Southern Asia (India, Pakistan, Bangladesh, Sri Lanka, Maldives), Southeastern Asia (Vietnam, Thailand, Indonesia, Philippines, Malaysia, Singapore, Myanmar, Cambodia, Laos, Brunei), and Western Asia (Middle East).

If you have any questions related to medical terminology or health-related topics, I'd be happy to help.

Phylogeny is the evolutionary history and relationship among biological entities, such as species or genes, based on their shared characteristics. In other words, it refers to the branching pattern of evolution that shows how various organisms have descended from a common ancestor over time. Phylogenetic analysis involves constructing a tree-like diagram called a phylogenetic tree, which depicts the inferred evolutionary relationships among organisms or genes based on molecular sequence data or other types of characters. This information is crucial for understanding the diversity and distribution of life on Earth, as well as for studying the emergence and spread of diseases.

The Measles-Mumps-Rubella (MMR) vaccine is a combination immunization that protects against three infectious diseases: measles, mumps, and rubella. It contains live attenuated viruses of each disease, which stimulate an immune response in the body similar to that produced by natural infection but do not cause the diseases themselves.

The MMR vaccine is typically given in two doses, the first at 12-15 months of age and the second at 4-6 years of age. It is highly effective in preventing these diseases, with over 90% effectiveness reported after a single dose and near 100% effectiveness after the second dose.

Measles is a highly contagious viral disease that can cause fever, rash, cough, runny nose, and red, watery eyes. It can also lead to serious complications such as pneumonia, encephalitis (inflammation of the brain), and even death.

Mumps is a viral infection that primarily affects the salivary glands, causing swelling and tenderness in the cheeks and jaw. It can also cause fever, headache, muscle aches, and fatigue. Mumps can lead to serious complications such as deafness, meningitis (inflammation of the membranes surrounding the brain and spinal cord), and inflammation of the testicles or ovaries.

Rubella, also known as German measles, is a viral infection that typically causes a mild fever, rash, and swollen lymph nodes. However, if a pregnant woman becomes infected with rubella, it can cause serious birth defects such as hearing impairment, heart defects, and developmental delays in the fetus.

The MMR vaccine is an important tool in preventing these diseases and protecting public health.

Drug labeling refers to the information that is provided on the packaging or container of a medication, as well as any accompanying promotional materials. This information is intended to provide healthcare professionals and patients with accurate and up-to-date data about the drug's composition, intended use, dosage, side effects, contraindications, and other important details that are necessary for safe and effective use.

The labeling of prescription drugs in the United States is regulated by the Food and Drug Administration (FDA), which requires manufacturers to submit proposed labeling as part of their new drug application. The FDA reviews the labeling to ensure that it is truthful, balanced, and not misleading, and provides accurate information about the drug's risks and benefits.

The labeling of over-the-counter (OTC) drugs is also regulated by the FDA, but in this case, the agency has established a set of monographs that specify the conditions under which certain active ingredients can be used and the labeling requirements for each ingredient. Manufacturers of OTC drugs must ensure that their labeling complies with these monographs.

In addition to the information required by regulatory agencies, drug labeling may also include additional information provided by the manufacturer, such as detailed instructions for use, storage requirements, and any warnings or precautions that are necessary to ensure safe and effective use of the medication. It is important for healthcare professionals and patients to carefully review and understand all of the information provided on a drug's labeling before using the medication.

Viral nonstructural proteins (NS) are viral proteins that are not part of the virion structure. They play various roles in the viral life cycle, such as replication of the viral genome, transcription, translation regulation, and modulation of the host cell environment to favor virus replication. These proteins are often produced in large quantities during infection and can manipulate or disrupt various cellular pathways to benefit the virus. They may also be involved in evasion of the host's immune response. The specific functions of viral nonstructural proteins vary depending on the type of virus.

A dose-response relationship in immunology refers to the quantitative relationship between the dose or amount of an antigen (a substance that triggers an immune response) and the magnitude or strength of the resulting immune response. Generally, as the dose of an antigen increases, the intensity and/or duration of the immune response also increase, up to a certain point. This relationship helps in determining the optimal dosage for vaccines and immunotherapies, ensuring sufficient immune activation while minimizing potential adverse effects.

BALB/c is an inbred strain of laboratory mouse that is widely used in biomedical research. The strain was developed at the Institute of Cancer Research in London by Henry Baldwin and his colleagues in the 1920s, and it has since become one of the most commonly used inbred strains in the world.

BALB/c mice are characterized by their black coat color, which is determined by a recessive allele at the tyrosinase locus. They are also known for their docile and friendly temperament, making them easy to handle and work with in the laboratory.

One of the key features of BALB/c mice that makes them useful for research is their susceptibility to certain types of tumors and immune responses. For example, they are highly susceptible to developing mammary tumors, which can be induced by chemical carcinogens or viral infection. They also have a strong Th2-biased immune response, which makes them useful models for studying allergic diseases and asthma.

BALB/c mice are also commonly used in studies of genetics, neuroscience, behavior, and infectious diseases. Because they are an inbred strain, they have a uniform genetic background, which makes it easier to control for genetic factors in experiments. Additionally, because they have been bred in the laboratory for many generations, they are highly standardized and reproducible, making them ideal subjects for scientific research.

Streptococcal vaccines are immunizations designed to protect against infections caused by Streptococcus bacteria. These vaccines contain antigens, which are substances that trigger an immune response and help the body recognize and fight off specific types of Streptococcus bacteria. There are several different types of streptococcal vaccines available or in development, including:

1. Pneumococcal conjugate vaccine (PCV): This vaccine protects against Streptococcus pneumoniae, a type of bacteria that can cause pneumonia, meningitis, and other serious infections. PCV is recommended for all children under 2 years old, as well as older children and adults with certain medical conditions.
2. Pneumococcal polysaccharide vaccine (PPSV): This vaccine also protects against Streptococcus pneumoniae, but it is recommended for adults 65 and older, as well as younger people with certain medical conditions.
3. Streptococcus pyogenes vaccine: This vaccine is being developed to protect against Group A Streptococcus (GAS), which can cause a variety of infections, including strep throat, skin infections, and serious diseases like rheumatic fever and toxic shock syndrome. There are several different GAS vaccine candidates in various stages of development.
4. Streptococcus agalactiae vaccine: This vaccine is being developed to protect against Group B Streptococcus (GBS), which can cause serious infections in newborns, pregnant women, and older adults with certain medical conditions. There are several different GBS vaccine candidates in various stages of development.

Overall, streptococcal vaccines play an important role in preventing bacterial infections and reducing the burden of disease caused by Streptococcus bacteria.

Pediatrics is a branch of medicine that deals with the medical care and treatment of infants, children, and adolescents, typically up to the age of 18 or sometimes up to 21 years. It covers a wide range of health services including preventive healthcare, diagnosis and treatment of physical, mental, and emotional illnesses, and promotion of healthy lifestyles and behaviors in children.

Pediatricians are medical doctors who specialize in this field and have extensive training in the unique needs and developmental stages of children. They provide comprehensive care for children from birth to young adulthood, addressing various health issues such as infectious diseases, injuries, genetic disorders, developmental delays, behavioral problems, and chronic conditions like asthma, diabetes, and cancer.

In addition to medical expertise, pediatricians also need excellent communication skills to build trust with their young patients and their families, and to provide education and guidance on various aspects of child health and well-being.

Anthrax vaccines are biological preparations designed to protect against anthrax, a potentially fatal infectious disease caused by the bacterium Bacillus anthracis. Anthrax can affect both humans and animals, and it is primarily transmitted through contact with contaminated animal products or, less commonly, through inhalation of spores.

There are two types of anthrax vaccines currently available:

1. Anthrax Vaccine Adsorbed (AVA): This vaccine is licensed for use in the United States and is approved for pre-exposure prophylaxis in high-risk individuals, such as military personnel and laboratory workers who handle the bacterium. AVA contains a cell-free filtrate of cultured B. anthracis cells that have been chemically treated to render them non-infectious. The vaccine works by stimulating the production of antibodies against protective antigens (PA) present in the bacterial culture.
2. Recombinant Anthrax Vaccine (rPA): This vaccine, also known as BioThrax, is a newer generation anthrax vaccine that was approved for use in the United States in 2015. It contains only the recombinant protective antigen (rPA) of B. anthracis, which is produced using genetic engineering techniques. The rPA vaccine has been shown to be as effective as AVA in generating an immune response and offers several advantages, including a more straightforward manufacturing process, fewer side effects, and a longer shelf life.

Both vaccines require multiple doses for initial immunization, followed by periodic booster shots to maintain protection. Anthrax vaccines are generally safe and effective at preventing anthrax infection; however, they may cause mild to moderate side effects, such as soreness at the injection site, fatigue, and muscle aches. Severe allergic reactions are rare but possible.

It is important to note that anthrax vaccines do not provide immediate protection against anthrax infection. They require several weeks to stimulate an immune response, so they should be administered before potential exposure to the bacterium. In cases of known or suspected exposure to anthrax, antibiotics are used as a primary means of preventing and treating the disease.

Dengue vaccines are designed to protect against dengue fever, a mosquito-borne viral disease that can cause severe flu-like symptoms and potentially life-threatening complications. Dengue is caused by four distinct serotypes of the virus (DENV-1, DENV-2, DENV-3, and DENV-4), and infection with one serotype does not provide immunity against the others.

The first licensed dengue vaccine, Dengvaxia (CYD-TDV), is a chimeric yellow fever-dengue tetravalent vaccine developed by Sanofi Pasteur. It is approved for use in several countries and has demonstrated efficacy against dengue fever caused by all four serotypes in clinical trials. However, the vaccine has raised concerns about the risk of severe disease in individuals who have not been previously exposed to dengue. As a result, it is recommended primarily for people with a documented past dengue infection or living in areas with high dengue prevalence and where the benefits outweigh the risks.

Another dengue vaccine candidate, Takeda's TAK-003 (also known as TDV), is a live attenuated tetravalent dengue vaccine that has shown efficacy against all four serotypes in clinical trials. It was granted approval by the European Medicines Agency (EMA) and several other countries for use in individuals aged 4-16 years old, living in endemic areas.

Research and development of additional dengue vaccine candidates are ongoing to address concerns about safety, efficacy, and accessibility, particularly for at-risk populations in low- and middle-income countries where dengue is most prevalent.

Drug-related side effects and adverse reactions refer to any unintended or harmful outcome that occurs during the use of a medication. These reactions can be mild or severe and may include predictable, known responses (side effects) as well as unexpected, idiosyncratic reactions (adverse effects). Side effects are typically related to the pharmacologic properties of the drug and occur at therapeutic doses, while adverse reactions may result from allergic or hypersensitivity reactions, overdoses, or interactions with other medications or substances.

Side effects are often dose-dependent and can be managed by adjusting the dose, frequency, or route of administration. Adverse reactions, on the other hand, may require discontinuation of the medication or treatment with antidotes or supportive care. It is important for healthcare providers to monitor patients closely for any signs of drug-related side effects and adverse reactions and to take appropriate action when necessary.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Virosomes are artificially constructed spherical vesicles composed of lipids and viral envelope proteins. They are used as a delivery system for vaccines and other therapeutic agents. In the context of vaccines, virosomes can be used to present viral antigens to the immune system in a way that mimics a natural infection, thereby inducing a strong immune response.

Virosome-based vaccines have several advantages over traditional vaccines. For example, they are non-infectious, meaning they do not contain live or attenuated viruses, which makes them safer for certain populations such as immunocompromised individuals. Additionally, virosomes can be engineered to target specific cells in the body, leading to more efficient uptake and presentation of antigens to the immune system.

Virosome-based vaccines have been developed for a variety of diseases, including influenza, hepatitis A, and HIV. While they are not yet widely used, they show promise as a safe and effective alternative to traditional vaccine approaches.

  • Health experts recommend that all children receive the rotavirus vaccine to prevent gastroenteritis , a disease that causes dehydration and vomiting. (schmidtlaw.com)
  • Rotavirus is the leading cause of a disease called acute gastroenteritis , which causes severe vomiting and diarrhea. (schmidtlaw.com)
  • A 2009 review estimated that vaccination against rotavirus would prevent about 45% of deaths due to rotavirus gastroenteritis, or about 228,000 deaths annually worldwide. (wikipedia.org)
  • Rotarix is indicated for the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) when administered as a 2-dose series in infants and children. (wikipedia.org)
  • Before the introduction of rotavirus vaccine in the United States in 2006, rotavirus infection was the leading cause of severe gastroenteritis among U.S. children. (cdc.gov)
  • Rotavirus was detected in 1844 (32.8%) of 5627 children with acute diarrhea that had stool specimens collected, and 93% of positive cases of rotavirus gastroenteritis were between 3 and 23 months of age, with highest prevalence in children 6-11 months of age. (lww.com)
  • The rotavirus causes a disease called acute gastroenteritis . (theclarkfirmtexas.com)
  • Infection with rotavirus reasons gastroenteritis additionally referred to as stomach flu. (healthlable.com)
  • In babies, rotavirus is the most not unusual purpose of gastroenteritis. (healthlable.com)
  • Rotavirus gastroenteritis (RVGE) is the most common cause of severe childhood diarrhea worldwide. (biomedcentral.com)
  • Effective August 1, 2021 Ontario will be transitioning from RotaTeq® vaccine (Rot-5, manufactured by Merck Canada) a three-dose vaccine series, to Rotarix® vaccine (Rot-1, manufactured by GlaxoSmithKline Inc.) a two-dose vaccine series, for the prevention of gastroenteritis caused by rotavirus infection in infants. (phsd.ca)
  • Wildi-Runge S, Allemann S, Schaad UB, Heininger U. A 4-year study on clinical characteristics of children hospitalized with rotavirus gastroenteritis. (folkhalsomyndigheten.se)
  • Iturriza-Gomara M, Auchterlonie IA, Zaw W, Molyneaux P, Desselberger U, Gray J. Rotavirus Gastroenteritis and Central Nervous System (CNS) Infection: Characterization of the VP7 and VP4 Genes of Rotavirus Strains Isolated from Paired Fecal and Cerebrospinal Fluid Samples from a Child with CNS Disease. (folkhalsomyndigheten.se)
  • The World Health Organization officially recommended rotavirus vaccines be included in all national immunization programs in 2009. (naturalnews.com)
  • Last week the World Health Organization recommended that rotavirus vaccination be included in all national immunization programs worldwide. (sciencedaily.com)
  • Making matters more difficult, the cost of national immunization programs is rising as new vaccines, such as those that protect individuals are more productive, earn against pneumonia and cervical cancer, are more expensive per dose than more, save more, invest more, consume traditional vaccines. (who.int)
  • Because vaccination is the only way to prevent hospitalizations from severe rotavirus infection in industrialized countries and the mortality it causes in low-resource settings, the World Health Organization (WHO) strongly recommends the inclusion of rotavirus vaccination into the national immunization programs of countries where clinical trials have shown rotavirus vaccines to be safe and effective. (path.org)
  • Introducing these vaccines into national immunization programs and reaching the unimmunized will require innovative solutions in which advocacy, education and communication is central. (who.int)
  • The WHO has recently recommended the inclusion of rotavirus vaccine in the national immunization programs of all countries. (smu.ac.za)
  • The rolling annualised percentage of children 'fully immunised' by 24 months of age for Australia decreased from the previous quarter by 1.1 percentage points to 90.1 (Table 2) This drop is likely to be due to the inclusion of the meningococcal C and varicella vaccines into the algorithm to calculate fully immunised coverage for this age group from the December 2014 quarter onwards. (health.gov.au)
  • Administration of routine childhood vaccinations (eg, hepatitis, polio, and meningococcal vaccines) is often prioritized over specific travel vaccines, as these diseases are still prevalent in many underdeveloped countries. (medscape.com)
  • MPSV4 (4-valent meningococcal polysaccharide vaccine) is no longer available and has been removed from the adult immunization schedule. (medscape.com)
  • Only two rotavirus vaccines are approved for infants in the U.S.: Merck's RotaTeq and GlaxoSmithKline's Rotarix. (naturalnews.com)
  • the FDA announced that RotaTeq vaccine was contaminated with DNA from two porcine circoviruses: PCV1 and PCV2. (naturalnews.com)
  • The two types of rotavirus vaccines are Rotarix and RotaTeq . (schmidtlaw.com)
  • As of 2013, there are two types of vaccine available globally, Rotarix and RotaTeq. (wikipedia.org)
  • A 2021 Cochrane systematic review concluded that Rotavac, RotaTeq, and Rotarix vaccines are safe and are effective at preventing diarrhea that is related to a rotavirus infection. (wikipedia.org)
  • RotaTeq is a live, oral pentavalent vaccine that contains five rotavirus strains produced by reassortment. (wikipedia.org)
  • Another rotavirus vaccine, RotaTeq® manufactured by Merck & Co., Inc., received FDA approval in 2006. (path.org)
  • Infants completing their vaccine series should receive the additional dose(s) of RotaTeq® vaccine required to complete this series, wherever possible. (phsd.ca)
  • Rotarix® and RotaTeq® vaccine products have different vaccination schedules and different age requirements for vaccine series completion. (phsd.ca)
  • Reserve any inventory of RotaTeq® in your vaccine fridges for infants who have previously received one or more doses of RotaTeq® vaccine. (phsd.ca)
  • It is anticipated that there will be enough provincial supply of RotaTeq® available for ordering to complete these vaccine series with the RotaTeq® product. (phsd.ca)
  • Pneumococcal conjugate vaccine, rubella-containing vaccine, measles-containing vaccine second dose, and Haemophilus influenzae type b vaccine have been introduced by 78%, 89%, 94%, and 99% of all countries, respectively. (medscape.com)
  • The measles, mumps, and rubella vaccine is not associated with autism. (aafp.org)
  • The measles, mumps, and rubella vaccine does not increase the risk of autism and should be routinely used. (aafp.org)
  • Coverage for individual vaccines due by 24 months remained high in all jurisdictions, except that coverage in all jurisdictions again decreased for the measles, mumps and rubella vaccine (by 0.7 to 1.3 percentage points). (health.gov.au)
  • Thanks to vaccines, what were once common childhood illnesses, like the measles or rubella, have become virtually non-existent in North America, and smallpox has been eradicated. (uniprix.com)
  • During his tenure as president of Merck Vaccines, Mahmoud spearheaded the development of vaccines against rotavirus, shingles and human papillomavirus, as well as a combination shot to prevent measles, mumps, rubella and chickenpox. (princeton.edu)
  • Discoveries at Wistar led to the creation of the rubella vaccine that eradicated the disease in the United States, human rabies vaccines used worldwide, and a new rotavirus vaccine approved in 2006. (health.am)
  • Infants who are moderately or severely ill should usually wait until they recover before getting rotavirus vaccine. (cdc.gov)
  • This additional risk is estimated to range from about 1 in 20,000 U.S. infants to 1 in 100,000 U.S. infants who get rotavirus vaccine. (cdc.gov)
  • In the team's earlier field work in children in Ghana and Pakistan, they found that infants with good immunity to the rotavirus vaccine had specific bacteria in their intestine. (sciencedaily.com)
  • While the results from this study are limited since rotavirus is a childhood disease and the microbiome of infants and children is different in adults, the researchers are buoyed that their microbiome/vaccine response theory deserves further study. (sciencedaily.com)
  • Harris emphasizes that this work does not advocate for antibiotic use in infants or children to boost rotavirus responses. (sciencedaily.com)
  • Safety and efficacy trials in Africa and Asia found that the vaccines dramatically reduced severe disease among infants in developing countries, where a majority of rotavirus-related deaths occur. (wikipedia.org)
  • Vaccines can help prevent serious illnesses in infants, children and adults. (challiance.org)
  • It's one order of magnitude to think about vaccination programs for infants and children -- the world has experience with that," Mahmoud said. (princeton.edu)
  • Infants born on or after June 1, 2021, should start their rotavirus vaccine series with the Rotarix® vaccine. (phsd.ca)
  • Order Rotarix® vaccine now for infants born after June 1, 2021, who will be due for their first dose of rotavirus vaccine in August 2021. (phsd.ca)
  • Once received, provide Rotarix® to all unimmunized infants meeting eligibility criteria for rotavirus vaccine. (phsd.ca)
  • Infants should get their first dose of hepatitis B vaccine at birth and will usually complete the series at 6-18 months of age. (medlineplus.gov)
  • The birth dose of hepatitis B vaccine is an important part of preventing long-term illness in infants and the spread of hepatitis B in the United States. (medlineplus.gov)
  • Rotavirus Infection in Infants as Protection against Subsequent Infections. (folkhalsomyndigheten.se)
  • A suspected case was vaccine was added to the national vaccination schedule defined as any previously well individual in Zamboanga of all infants aged between 1.5 and 3.5 months. (who.int)
  • Worldwide, rotavirus is the leading cause of severe diarrhea in infants and young children. (cdc.gov)
  • Another virus called "porcine circovirus" can be found in one brand of rotavirus vaccine (Rotarix). (cdc.gov)
  • Rotarix is a monovalent, human, live attenuated rotavirus vaccine containing one rotavirus strain of G1P[8] specificity. (wikipedia.org)
  • Their Rotarix vaccine is available in 36 Gavi countries to protect against rotavirus. (globalhealthprogress.org)
  • You do not need to have a specific vaccine injury to qualify for a rotavirus vaccine lawsuit. (schmidtlaw.com)
  • If the rotavirus vaccine caused your child to suffer a severe vaccine side effect, you may qualify for a rotavirus vaccine lawsuit. (theclarkfirmtexas.com)
  • Therefore, many different types of side effects could potentially qualify for a rotavirus vaccine lawsuit. (theclarkfirmtexas.com)
  • Babies should get 2 or 3 doses of rotavirus vaccine, depending on the brand of vaccine used. (cdc.gov)
  • So, of the 11 types of vaccines approved for pediatric use (and given in 36 doses because many are given multiple times), Oregon says you need to prove your child received 6 of them to enter kindergarten, or just over half of the vaccines recommended by CDC. (ageofautism.com)
  • The Rotavirus vaccine is administered by mouth and requires two or three doses starting around six weeks of age. (marketresearchfuture.com)
  • These vaccines are administered in several doses before the child is 6 months old. (theclarkfirmtexas.com)
  • Having analyzed facts from nearly 1.5 million children within the United States between 2001 and 2017, the take a look at authors pronounced a 41% reduction in new cases of type 1 diabetes at some point of this time in kids who acquired all doses of the rotavirus vaccine. (healthlable.com)
  • Despite the global delivery of roughly 15 billion doses through different mechanisms as of October 2022, only 12% of this total came from COVAX, a worldwide global alliance for equitable access to Covid vaccines. (grandviewresearch.com)
  • This coordinated effort, which involved mobilizing 2.3 million volunteer vaccinators to reach 170 million children with repeated doses of oral polio vaccine, led to India being declared polio-free in 2014. (gatesfoundation.org)
  • GSK is the leading vaccines company - they deliver over two million vaccine doses per day and more than 945 million vaccine doses since 2010 to people living in 158 countries. (globalhealthprogress.org)
  • They have committed to deliver 720 million doses of their pneumococcal vaccine, Synflorix, to Gavi through the Advance Market Commitment (AMC) at a discounted price up to 2024. (globalhealthprogress.org)
  • In 2018, they delivered over 120 million doses of vaccines to Gavi. (globalhealthprogress.org)
  • In 2018, they distributed around two million doses of the vaccine Cervarix in Zimbabwe in support of its multi-age cohort vaccination program to protect over 800,000 girls against human papillomavirus and have also supported Gavi pilots of our Cervarix vaccine for human papillomavirus (HPV) in 12 countries since 2012. (globalhealthprogress.org)
  • Fully immunised' at 60 months of age is defined as a child having a record on the ACIR of 4 doses of a DTP-containing vaccine, 4 doses of polio vaccine, and 2 doses of an MMR-containing vaccine. (health.gov.au)
  • The VE against notified pertussis was 96.4% (95% CI: 94.7, 97.6) for the first three doses of wP vaccine (2000-2007) and 95.7% (95% CI: 95.1, 96.2) for the first three doses of aP vaccine (2008-2019). (bvsalud.org)
  • 11. Prior to study vaccination has received no doses of IPV or OPV or rotavirus vaccine, based upon documentation or parental history. (who.int)
  • Persons ≥ 12 months who previously received ≤ two doses of mumps-containing vaccine and are identified by public health authorities to be at increased risk during a mumps outbreak should receive a dose of mumps virus-containing vaccine. (medscape.com)
  • Administer one dose of MMR to adults who previously received ≤ two doses of mumps-containing vaccine and are identified by a public health authority to be at increased risk during a mumps outbreak. (medscape.com)
  • Two rotavirus vaccines that have 34 countries approved by GAVI Alliance for financial sup- been prequalified by the World Health Organization, Rotar- port, but rotavirus vaccine has not yet been introduced in ix (GlaxoSmithKline Biologicals, Rixensart, Belgium) and the country. (cdc.gov)
  • This report describes the status of introductions globally for eight World Health Organization (WHO)-recommended new and underutilized vaccines, comprising 10 individual vaccine antigens. (medscape.com)
  • The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. (wikipedia.org)
  • In April 2016, the World Health Organization released statistics for the period of 2000-2013, which showed developing countries that have introduced rotavirus vaccines experienced significant decreases in deaths and hospitalizations from rotavirus diarrhea after introduction. (wikipedia.org)
  • The World Health Organization recommends the first dose of vaccine be given right after six weeks of age. (wikipedia.org)
  • These include the Institute of Medicine (IOM), the National Academy of Sciences (NAS), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the National Vaccine Advisory Committee (NVAC), the Advisory Commission on Childhood Vaccines (ACCV), the National Institutes of Health (NIH) and the World Health Organization (WHO). (immunizationinfo.org)
  • Mahmoud, a member of the Expert Advisory Panel on Parasitic Diseases of the World Health Organization (WHO), is now conducting research to understand and overcome roadblocks to more widespread use of the vaccines. (princeton.edu)
  • The World Health Organization has called on all countries to help make rotavirus vaccines widely available. (cdc.gov)
  • We found that the weakened live virus in the vaccine replicates at a higher level in antibiotic-treated recipients," says co- first author Vanessa Harris, of the Amsterdam Institute for Global Health and Development and the Division of Infectious Diseases and Center for Experimental and Molecular Medicine at the Amsterdam Medical Center, the Netherlands. (sciencedaily.com)
  • Medicare 's vaccine coverage helps eligible members reduce their risk of contracting diseases, and at a minimal cost. (medicalnewstoday.com)
  • It consists of a series of modules that discuss vaccine-preventable diseases and explain the latest recommendations for vaccine use. (cdc.gov)
  • Participants should have a basic educational background in science including general knowledge in the subject areas of biology, immunization and vaccine-preventable diseases. (cdc.gov)
  • Moreover, vaccine-preventable diseases (VPDs) contribute to an estimated 20% of under-five deaths. (who.int)
  • The regional vision of "no child should die from vaccine-preventable diseases," the Global Immunization Vision and Strategy, and the Bill and Melinda Gates Foundation Decade of Vaccines announcement have set out a unifying response to the challenges of a rapidly changing and increasingly interdependent world. (who.int)
  • They aim is to protect more people against more diseases, invest in research and development, strengthen public private partnerships, introduce new vaccines and link immunization with the delivery of other health interventions. (who.int)
  • This event can be leveraged to bridge immunization gaps, introduce and expand the use of new vaccines, prevent and respond to vaccine-preventable diseases in outbreaks and humanitarian crises, and achieve regional and national goals for accelerated disease control, elimination and eradication. (who.int)
  • Vaccines are our best defense from many serious diseases. (challiance.org)
  • Rotavirus vaccines can cause severe bowel obstruction ( intussusception ), allergic reactions, autoimmune diseases, and more. (theclarkfirmtexas.com)
  • The purpose of the ITFDE was to establish criteria and apply them systematically to evaluate the potential eradicability of other diseases in the aftermath of the Smallpox Eradication Program. (cdc.gov)
  • Over time, the range of vaccines available worldwide has been growing steadily, with the creation of new vaccines aimed at diseases that typically impact lower-income countries. (grandviewresearch.com)
  • The success of mRNA-based COVID-19 vaccines has given impetus to the development of mRNA platforms for the prevention of various infectious diseases such as flu and RSV. (grandviewresearch.com)
  • The subunit vaccines segment is estimated to have the fastest CAGR during the forecast period, owing to the increasing incidence of infectious diseases, the rising demand for safe & effective vaccines, and the growing focus on preventive healthcare. (grandviewresearch.com)
  • The growing need for more effective vaccines against diseases such as cancer, autoimmune disorders, and allergies is also driving the demand for subunit vaccines. (grandviewresearch.com)
  • For instance, in November 2022, Curevo Vaccine (Curevo), a clinical-stage biotechnology company that aims to develop safe and effective vaccines to reduce the burden of infectious diseases, announced the completion of a Series A1 funding round worth $26 million. (grandviewresearch.com)
  • Family physicians should gather accurate information about the harms and benefits of vaccines to advocate for vaccination and decrease the incidence of vaccine-preventable diseases. (aafp.org)
  • Immunizations have reduced by more than 95 to 99 percent the vaccine- preventable infectious diseases in this country although the causative agents (except for smallpox) persist in epidemic or endemic burdens elsewhere in the world. (immunizationinfo.org)
  • It is a function of two things: the performance of the vaccines and their use broadly in the population, the latter largely a function of the increasing importance that most parents and all clinicians place on protecting children from diseases that are easily prevented with vaccines. (immunizationinfo.org)
  • Three of the seven sero-groups of rotavirus identified affect humans, known as groups A-C. The most dominant, group A, causes diarrheal diseases worldwide [ 2 ]. (biomedcentral.com)
  • This program received direct funding and preclinical services from the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, under Contract Numbers HHSN272200800056C, and HHSN272201000006I and HHSN272201200003I, respectively. (jnj.com)
  • In addition to the vaccines required for school entry, the ACIP recommends several vaccines that provide protection against other diseases. (psdschools.org)
  • Each year, millions of people around the world die of preventable diseases because they lack access to vaccines, treatments, and diagnostic tools. (gatesfoundation.org)
  • To develop, produce, and deliver lifesaving tools in these regions, we work with the private sector in China on vaccines for Japanese encephalitis, polio, cervical cancer, and other deadly diseases, as well as cold-chain equipment for regions with poor infrastructure, artemisinin-based combination treatments for malaria, and long-acting contraceptive implants. (gatesfoundation.org)
  • The National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS) provides commentary on the trends in the Australian Childhood Immunistaion Register data for children vaccinated at 12, 24 and 60 months of age. (health.gov.au)
  • The National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS) provides commentary on the trends in ACIR data. (health.gov.au)
  • Children receive a number of vaccines starting at a young age to protect them against common childhood diseases. (uniprix.com)
  • Immunization prevents most childhood diseases, but there are some for which a vaccine doesn't exist. (uniprix.com)
  • An authority on the development and deployment of vaccines, Mahmoud has learned firsthand that the importance of a multidisciplinary approach to tackling infectious diseases cannot be overestimated. (princeton.edu)
  • Wistar Institute Vaccine Center scientists are creating new vaccines against pandemic influenza, HIV, and other diseases threatening global health. (health.am)
  • Specific travel vaccines (eg, typhoid fever, yellow fever, Japanese encephalitis) are the next consideration, as these diseases are endemic in many resource-limited countries. (medscape.com)
  • In keeping with this mission, CDC has strategic plans that address certain specific infectious disease threats, including HIV/AIDS, TB, STDs, and selected vaccine-preventable diseases. (cdc.gov)
  • and emerging diseases necessitate the ongoing assessment of vaccine development priorities (e.g., pneumococcal disease in children, respiratory syncytial virus [RSV] pneumonia, malaria). (cdc.gov)
  • To provide the vigilance and rapid response required to effectively address emerging infectious diseases, significant improvements in public health policy, program design, and infrastructure are needed. (cdc.gov)
  • A strong public health infrastructure at national, $4,360,695 state, and local levels is vital to sustaining high vaccination coverage levels and low incidence of vaccine prevent- able diseases. (cdc.gov)
  • New Vaccine Surveillance Network (NVSN): conducts active, population-based surveillance of pediatric infec- tious diseases and assesses the effectiveness of pediatric vaccines in the US. (cdc.gov)
  • The EIP network gathers laboratory and population-based information for many vaccine-preventable, invasive bacterial and respiratory diseases, as well as diseases for which vaccines are in development. (cdc.gov)
  • If you or your loved one was injured by rotavirus vaccine side effects, it is essential that you immediately contact a rotavirus vaccine lawyer. (schmidtlaw.com)
  • If your child has suffered a serious rotavirus vaccine side effect, contact a rotavirus vaccine lawyer immediately for more information about your legal rights. (theclarkfirmtexas.com)
  • Rotavirus commonly causes severe, watery diarrhea, mostly in babies and young children. (cdc.gov)
  • Almost all babies who get rotavirus vaccine will be protected from severe rotavirus diarrhea. (cdc.gov)
  • Irritability or mild, temporary diarrhea or vomiting can happen after rotavirus vaccine. (cdc.gov)
  • But each year an estimated two million children are hospitalized because rotavirus infection results in severe dehydration caused by diarrhea and vomiting. (sciencedaily.com)
  • The rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. (wikipedia.org)
  • The vaccines prevent 15-34% of severe diarrhea in the developing world and 37-96% of the risk of death among young children due to severe diarrhea. (wikipedia.org)
  • Gaithersburg, MD, February 20, 2008-The US Advisory Committee on Vaccines and Related Biological Products issued a positive recommendation today on the use of rotavirus vaccines, potentially bringing greater protection to children in the United States from this common and sometimes fatal cause of severe diarrhea. (path.org)
  • The market symptoms of rotavirus infection are inclusive of severe diarrhea, vomiting, fever, and abdominal pain which can result in disease. (marketresearchfuture.com)
  • Rotavirus vaccine is known to be applied to gain prevention against rotavirus infections which can cause severe diarrhea that is more prevalent amongst young children. (marketresearchfuture.com)
  • The symptoms of rotavirus infection are inclusive of severe diarrhea, and other issues like vomiting, fever, and abdominal pain. (marketresearchfuture.com)
  • To determine the prevalence of severe rotavirus infection in children admitted with acute diarrhea attending Mulago National Referral Hospital in Uganda, active sentinel surveillance was conducted from July 2006 to December 2012. (lww.com)
  • A total of 6387 children with acute diarrhea were enrolled into the public health surveillance system and of these, 5627 had stool samples collected and tested for rotavirus antigens by enzyme immunoassay ProSpecT Rotavirus kit. (lww.com)
  • Uganda would benefit by introducing rotavirus vaccine and hence reduce the hospitalization burden of managing acute diarrhea cases. (lww.com)
  • Unpublished work (Kenya-Mugisha, 1989) from the 1980s found that rotavirus was responsible for 57% of acute watery diarrhea among the children studied. (lww.com)
  • Majority of these deaths are due to pneumococcal disease and rotavirus diarrhea which can be partially prevented through newly available vaccines. (who.int)
  • More than two decades ago, when Bill Gates and Melinda French Gates were both working at Microsoft, they came across a newspaper article about a highly contagious diarrhea-causing virus called rotavirus that was responsible for the deaths of hundreds of thousands of children each year in low-income countries. (gatesfoundation.org)
  • Her research focuses on childhood diarrhea and the evaluation of vaccine effectiveness. (unc.edu)
  • Dr. Becker-Dreps' research focuses on childhood diarrhea and the evaluation of vaccine effectiveness. (unc.edu)
  • A novel equine rotavirus group B pathogen was implicated in the disease based on compelling genetic sequencing evidence coupled with the clinical scenario of a highly contagious pathogen that causes diarrhea in foals under 4 days of age. (thehorse.com)
  • In countries in the Americas, Europe and Australia that have adopted routine childhood immunization against rotavirus, significant reductions in the burden of severe childhood diarrhea have been observed. (smu.ac.za)
  • Consider rotavirus, which causes severe diarrhea and is responsible for 600,000 deaths every year, 99 percent of which occur outside the United States and Europe. (princeton.edu)
  • After injuries or exposure, people with Medicare can also receive tetanus and rabies preventative vaccines. (medicalnewstoday.com)
  • The Tdap vaccine provides protection against tetanus, diphtheria and whooping cough. (challiance.org)
  • 3 The fourth dose of the diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine is associated with an increased incidence of fever and injection site reactions compared with the first dose (one in four children). (aafp.org)
  • or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. (aafp.org)
  • With considerable international support, diphtheria, tetanus, and pertussis (DTP) vaccine coverage has risen from 37% in 1997 to 96% in 2013. (plos.org)
  • External agency estimates of diphtheria, tetanus, and pertussis (DTP) vaccine coverage fell below 40% during this period [ 5 ]. (plos.org)
  • The Tetanus-diphtheria-acellular pertussis (Tdap) vaccine was recommended in the Mexican Immunisation Programme for pregnant women in 2013. (bvsalud.org)
  • To ensure every child receives the vaccines they need, governments measles, polio and pneumonia. (who.int)
  • To evaluate the long-term impact of rotavirus vaccination on disease prevalence and seasonality in the United States, CDC analyzed national laboratory testing data for rotavirus from laboratories participating in CDC's National Respiratory and Enteric Viruses Surveillance System (NREVSS) during the prevaccine (2000-2006) and postvaccine (2007-2018) periods. (cdc.gov)
  • Results of all enzyme immunoassay (EIA) tests for rotavirus conducted during July 2000-June 2018 were obtained from laboratories participating in NREVSS. (cdc.gov)
  • To examine trends in rotavirus testing and detection during the prevaccine and postvaccine periods, analyses were restricted to the 23 laboratories that continuously reported rotavirus testing results for ≥26 weeks of each reporting year during July 2000-July 2018. (cdc.gov)
  • The global vaccine market size was estimated at USD 124.2 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 1.4% from 2023 to 2030. (grandviewresearch.com)
  • Excluding the impact of COVID-19, the vaccine market is expected to grow at a CAGR of 8.6% from 2023 to 2030. (grandviewresearch.com)
  • In the U.S., the COVID vaccine market is anticipated to go commercial by the second half of 2023 as the stock purchased by the federal government will be exhausted. (grandviewresearch.com)
  • For instance, in March 2023, Moderna announced that its COVID vaccine market price will increase to around USD 110 to USD 130 per dose. (grandviewresearch.com)
  • These signs would usually happen during the first week after the first or second dose of rotavirus vaccine, but look for them any time after vaccination. (cdc.gov)
  • 70% of the rotavirus infections in North America, Europe, G2P[4] predominated. (cdc.gov)
  • The incidence and severity of rotavirus infections has declined significantly in countries that have acted on the recommendation to introduce the rotavirus vaccine. (wikipedia.org)
  • Additionally, the vaccines may also prevent illness in non-vaccinated children by limiting exposure through the number of circulating infections. (wikipedia.org)
  • However, with the onset of the coronavirus disease 2019 (COVID-19) pandemic, and amid focus on vaccines as the only definitive method of durable control, a new study describes the possibility of producing a combined vaccine against both infections. (news-medical.net)
  • Rotavirus infections occurred throughout the year. (lww.com)
  • Infections with rotavirus had been commonplace in new child nurseries. (healthlable.com)
  • The foundation began working in India in 2003 with the launch of Avahan, an HIV prevention program that is estimated to have prevented 600,000 new infections. (gatesfoundation.org)
  • Rotavirus kills over 200,000 children each year and is the most important cause of diarrheal death in children. (sciencedaily.com)
  • In Mexico, which in 2006 was among the first countries in the world to introduce rotavirus vaccine, the diarrheal disease death rates from rotavirus dropped by more than 65% among children age two and under during the 2009 rotavirus season. (wikipedia.org)
  • Rotavirus is a common diarrheal disease that affects young children. (news-medical.net)
  • The annual rate of new vaccine introductions declined precipitously when the COVID-19 pandemic started, from 48 in 2019 to 15 in 2020 before rising to 26 in 2021. (medscape.com)
  • Increased efforts to accelerate new and underutilized vaccine introductions are urgently needed to improve universal equitable access to all recommended vaccines to achieve the global Immunization Agenda 2021-2030 (IA2030) targets. (medscape.com)
  • The global Immunization Agenda 2021-2030 (IA2030), by increasing equitable access to and use of new and existing vaccines, envisions a world where everyone everywhere fully benefits from vaccines. (medscape.com)
  • These are all aspects that are driving the Human Rotavirus Vaccine Market forward as per the predictions that have been made for the forecast period of 2021-2028. (marketresearchfuture.com)
  • The human rotavirus vaccine market is further, witnessing a rise in the prices of the vaccines and the adverse reactions alongside the increased side effects of the vaccine that are further estimated to bar the human rotavirus vaccine market shortly, as a part of the ongoing forecast period of 2021-2028. (marketresearchfuture.com)
  • The rise in the production scales of the vaccines is escalating the growth of the human rotavirus vaccine market as per the predictions of the experts for the forecast period of 2021-2028. (marketresearchfuture.com)
  • Gavi's five-year (2021-2025) strategy ('Gavi 5.0') envisions to 'leave no-one behind with immunization' and aims to save lives and protect people's health by increasing equitable and sustainable use of vaccines. (globalhealthprogress.org)
  • 2021). Rotavirus infection, illness, and vaccine performance in malnourished children: a review of the literature. (cdc.gov)
  • Previous research has shown that vaccines protect children against the disease but that they work less well in low-income settings. (sciencedaily.com)
  • Instead, the researchers view these results as a starting point with great potential for altering the microbiome to improve vaccine performance and ultimately better protect children in low-income settings from rotavirus, which continues to be a life-threatening disease. (sciencedaily.com)
  • Vaccines against rotavirus remain the most effective way to prevent this deadly disease," notes Dr. John Wecker, director of PATH's Rotavirus Vaccine Program. (path.org)
  • Historically, rotavirus disease exhibited a winter-spring seasonality, with the season beginning in December-January and ending in April-May ( 4 ). (cdc.gov)
  • If symptoms of the disease occurred before vaccination, then the vaccine is not the cause. (immunizationinfo.org)
  • In the case of a live virus vaccine, a causal relationship between vaccine and disease may often be inferred if the virus is recovered from a normally sterile body site (for example, blood or cerebral spinal fluid). (immunizationinfo.org)
  • Causation may be inferred if the adverse event or disease only occurs following vaccination and does not occur in persons who did not receive the vaccine. (immunizationinfo.org)
  • and epidemiology cannot prove the negative-that means it cannot prove that a vaccine does not cause a disease. (immunizationinfo.org)
  • For Rotavirus, describe this disease, including the causative agent. (cdc.gov)
  • For Rotavirus, describe characteristics of the vaccine used to prevent this disease. (cdc.gov)
  • The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program. (cdc.gov)
  • Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1 total Category I continuing education contact hours. (cdc.gov)
  • Click here to learn more about these vaccines from the Centers for Disease Control and Prevention. (challiance.org)
  • According to the Center for Disease Control and Prevention, those receiving the Moderna vaccine should receive the second dose 28 days after the first dose. (health.mil)
  • Once a Sailor or Marine is fully vaccinated with both their first and second dose of the Moderna vaccine, they should expect over ninety-four percent efficacy in preventing disease from COVID-19, which will virtually eliminate the risk of severe disease or death during an outbreak at sea," said Navy Cmdr. (health.mil)
  • Although health experts recommend all children get this immunization to prevent life-threatening disease, once in a while, the vaccine itself can actually causes severe side effects. (theclarkfirmtexas.com)
  • Globally, viruses carrying either G1, G2, G3, G4, G9 and P[4] or P[8] are the most common causes of rotavirus disease in humans. (biomedcentral.com)
  • Prime-boost vaccine regimens involve an initial dose that primes the immune system to develop disease-specific antibodies, followed by a booster dose at a later date that can strengthen and optimize the duration of the immune response. (jnj.com)
  • Unfortunately, the development of an efficacious vaccine has lagged behind, and disease control has focused on prevention through the implementation of increased biosecurity protocols. (thehorse.com)
  • Live, oral rotavirus vaccines are more effective at preventing rotavirus disease in countries with low child mortality compared with high child mortality. (cdc.gov)
  • This vaccine may also be recommended after the age of 2 for children with certain health conditions (e.g., asthma, diabetes or another chronic disease). (uniprix.com)
  • Foals from vaccinated mares are spared the growth rate check caused by rotavirus disease. (theanimalpharmacy.com.au)
  • Hepatitis B vaccine can prevent hepatitis B . Hepatitis B is a liver disease that can cause mild illness lasting a few weeks, or it can lead to a serious, lifelong illness. (medlineplus.gov)
  • Nosocomial Rotavirus Infection in European Countries: A Review of the Epidemiology, Severity and Economic Burden of Hospital-Acquired Rotavirus Disease. (folkhalsomyndigheten.se)
  • Vaccines are one of the most effective tools to protect the public's health and prevent disease. (cdc.gov)
  • This improves CDC's understanding of why vaccine-preventable disease outbreaks occur, $259,755 risk factors for disease, and our ability to respond to outbreaks when they happen. (cdc.gov)
  • Announcer] This program is presented by the Centers for Disease Control and Prevention. (cdc.gov)
  • When developing vaccine recommendations for children and adults, ACIP considers many factors, including disease epidemiology, vaccine safety and effectiveness, feasibility of program implementation, and economics of immunization policy. (medscape.com)
  • The pneumococcal row for the heart disease/chronic lung disease, chronic liver disease, and diabetes columns has been stippled to clarify that, in some situations, an additional dose of vaccine may be recommended for children with these conditions. (medscape.com)
  • Two vaccines (influenza and hepatitis A) are available only to privately insured children of a certain age. (ct.gov)
  • Medicare members with a medium to high risk of contracting hepatitis B also qualify for a preventative vaccine. (medicalnewstoday.com)
  • Some other factors can also increase the likelihood of contracting hepatitis B. Anyone concerned about their risk should ask their doctor about their vaccine eligibility. (medicalnewstoday.com)
  • Most people who are vaccinated with hepatitis B vaccine are immune for life. (medlineplus.gov)
  • Hepatitis B vaccine is usually given as 2, 3, or 4 shots. (medlineplus.gov)
  • Hepatitis B vaccine may be given as a stand-alone vaccine, or as part of a combination vaccine (a type of vaccine that combines more than one vaccine together into one shot). (medlineplus.gov)
  • Hepatitis B vaccine may be given at the same time as other vaccines. (medlineplus.gov)
  • Hepatitis B (HBV) vaccine is included in routine childhood immunization vaccines to prevent chronic HBV infection. (medscape.com)
  • BACKGROUND: Hepatitis A virus (HAV) infection is a leading cause of viral hepatitis in children, yet the HAV vaccine is not included in the national immunization program (NIP) in Mexico. (bvsalud.org)
  • These genotypes represented 88% of all rotavirus strains tavirus positive. (cdc.gov)
  • The rotavirus A parent strains of the reassortants were isolated from human and bovine hosts. (wikipedia.org)
  • All Medicare members qualify for influenza and pneumococcal vaccines, which can protect against the various strains of influenza and pneumonia. (medicalnewstoday.com)
  • The influenza vaccine changes annually to adapt to new and changing strains. (medicalnewstoday.com)
  • The vaccines showed superior results against influenza A strains but fell short against certain influenza B strains. (grandviewresearch.com)
  • Rotaviruses are ubiquitous in the animal kingdom, and therefore, interspecies transmission and more importantly, exchange of genetic material between animal and human strains through re-assortment can lead to the emergence of novel rotavirus strains of epidemiological significance [ 9 ]. (biomedcentral.com)
  • One regulation worth mentioning has to do with rotavirus vaccines and a condition called intussusception. (naturalnews.com)
  • One of 3,415 new rules (which surely should've been in place when rotavirus vaccines first began being administered) officially adds intussusception [2] to the Vaccine Injury Table for rotavirus vaccines under the National Vaccine Injury Compensation Program. (naturalnews.com)
  • However, recent data point to a small risk of intussusception, and the rule amends the Vaccine Injury Table to provide for this adverse event. (naturalnews.com)
  • According to the VAERS Database at the time of writing this article, of the nearly 11,000 adverse events reported in children under three after receiving a rotavirus vaccine, there are 532 incidents listed where a child under the age of 3 received a rotavirus vaccine and later presented with intussusception. (naturalnews.com)
  • There is also a small risk of intussusception from rotavirus vaccination, usually within a week after the first or second vaccine dose. (cdc.gov)
  • In rare cases, children who are immunized with the rotavirus vaccine have developed severe bowel obstruction ( intussusception ), allergic reactions, autoimmune responses, and other life-threatening side effects. (schmidtlaw.com)
  • The previous rotavirus vaccine (RotaShield) was withdrawn in 1999 due to a risk of intussusception , a type of bowel obstruction that can cause severe intestinal damage. (schmidtlaw.com)
  • RotaShield is a rotavirus vaccine that was recalled in 1999 after being associated with an increased risk of intussusception , a type of bowel obstruction that can cause severe intestinal damage. (theclarkfirmtexas.com)
  • The newer vaccines are currently being evaluated regarding the risk of intussusception. (theclarkfirmtexas.com)
  • The rotavirus vaccine minimally increases the rate of intussusception, whereas other vaccines minimally increase the risk of syncope. (aafp.org)
  • Virtually every child in the world becomes infected with rotaviruses before developing natural immunity. (sciencedaily.com)
  • Both natural and vaccine-induced immunity occur only after the immune system has "seen" the virus and generates neutralizing antibodies. (sciencedaily.com)
  • The factors contributing to the growth of the human rotavirus vaccine market include increased development alongside an increase in the number of people with weakened immunity. (marketresearchfuture.com)
  • As you get older, your immunity from your childhood vaccines may wear off. (challiance.org)
  • A number of widely used vaccines use a multi-dose approach to create stronger and longer-lasting immunity, including some for polio, rotavirus and HPV. (jnj.com)
  • Clinical immunity after neonatal rotavirus infection. (folkhalsomyndigheten.se)
  • Adverse reactions should be reported to the Vaccine Adverse Event Reporting System (VAERS). (cdc.gov)
  • The Vaccine Adverse Event Reporting System and National Vaccine Injury Compensation Program track adverse events and allow compensation for documented harms from vaccinations. (aafp.org)
  • Thanks to Gavi support since 2005, MINSA has been able to offer some of the newer and more expensive vaccines, such as the rotavirus and pneumococcal vaccines, free of charge, as well. (csis.org)
  • In addition, there is clarification of the recommendations for rotavirus and pneumococcal vaccines. (medscape.com)
  • Ongoing efforts to improve coverage and on-time vaccination can help maximize the public health impact of rotavirus vaccination. (cdc.gov)
  • She has evaluated the impact of rotavirus immunization programs in Nicaragua and the US and is currently conducting studies to understand why rotavirus vaccines have lower effectiveness in low-income settings. (unc.edu)
  • The proceeds from the financing will be used to support the development of CRV-101, a clinical-stage adjuvanted sub-unit vaccine that is being investigated for its potential in preventing shingles in older adults. (grandviewresearch.com)
  • 2011 -R -04 39 , which describes Connecticut's childhood immunization program. (ct.gov)
  • s childhood immunization program. (ct.gov)
  • Please refer to the accompanying health care provider Q&A provided by the Ministry of Health for further information on rotavirus infection and the vaccine products available for prevention. (phsd.ca)
  • Investments in Connecticut support national efforts to improve influenza prevention through vaccination and $948,991 col ect data that helps decide the makeup of the next season's flu vaccine. (cdc.gov)
  • 200,000 also provides an infrastructure for further public health vaccine research, including post-licensure vaccine efficacy evaluations and analyses of the effectiveness of prevention policies. (cdc.gov)
  • Steve Monroe] The main differences between norovirus and rotavirus are in the age of people most affected and in the approaches we use for control and prevention. (cdc.gov)
  • Four reassortant rotaviruses express one of the outer capsid, VP7, proteins (serotypes G1, G2, G3, or G4) from the human rotavirus parent strain and the attachment protein VP4 (type P7) from the bovine rotavirus parent strain. (wikipedia.org)
  • The fifth reassortant virus expresses the attachment protein VP4, (type P1A), from the human rotavirus parent strain and the outer capsid protein VP7 (serotype G6) from the bovine rotavirus parent strain. (wikipedia.org)
  • The human rotavirus vaccine market revenue is likely to reach a final value worth Significant Value for the ongoing forecast period of 2022-2030. (marketresearchfuture.com)
  • The human rotavirus vaccine market has been one of the affected markets since the coronavirus infection has turned into a pandemic and is facing adversities ever since. (marketresearchfuture.com)
  • Some major factors are projected to promote the growth of the Human Rotavirus Vaccine Market size in the forecast period that will be ending in 2028. (marketresearchfuture.com)
  • But, the human rotavirus therapeutics market is witnessing a substantial decrease in healthcare expenses in most of the advancing countries. (marketresearchfuture.com)
  • This is one of the major reasons that is restraining the human rotavirus vaccine market from growing during the forecast period that will be ending in 2028. (marketresearchfuture.com)
  • Knowledge of rotavirus epidemiology is necessary to where their effect on rotavirus-related hospital admissions make informed decisions about vaccine introduction and to and deaths has been demonstrated ( 3 ). (cdc.gov)
  • Dr. Becker-Dreps is Director of the UNC Program in Nicaragua, Director of the Office of Global Health Education, and Professor in the Department of Epidemiology. (unc.edu)
  • A comprehensive literature search was conducted in major databases on the epidemiology and burden of rotavirus among children less than five years old between 1999 and 2009. (biomedcentral.com)
  • Nationally, the median annual percentage of tests positive for rotavirus declined from 25.6% (range = 25.2-29.4) in the prevaccine period to 6.1% (range = 2.6-11.1) in the postvaccine period. (cdc.gov)
  • Peak rotavirus activity is defined as the highest proportion of tests positive for rotavirus during a single week in a given reporting year. (cdc.gov)
  • The beginning and end of the rotavirus season are defined as the first and last, respectively, of 2 consecutive weeks in which ≥10% of the tests are positive for rotavirus. (cdc.gov)
  • Trends in testing practices over time were evaluated using the Spearman rank order correlation for the annual number of tests conducted and the Cochran-Armitage test for trend for the annual proportions of tests that were positive for rotavirus. (cdc.gov)
  • Of the 93 stool specimens collected, 56 (60%) were positive for rotavirus. (who.int)
  • Five samples from water refilling stations where case patients reported collecting drinking water were all positive for rotavirus. (who.int)
  • Conclusions No associations were observed between exposure to pH1N1 influenza vaccine during pregnancy and most five year pediatric health outcomes. (bmj.com)
  • Thimerosal is currently used only in multidose vials of influenza vaccine, and exposure through vaccines is not associated with adverse neurologic outcomes. (aafp.org)
  • Polio vaccine. (medscape.com)
  • The inactivated poliovirus rows of the catch-up schedule have been edited to clarify the catch-up recommendations for children 4 years of age and older, and the poliovirus vaccine footnote was revised to include updated guidance for persons who received oral polio vaccine as part of their vaccination series. (medscape.com)
  • In the United States, where rotavirus vaccination is routine, hospitalizations and deaths due to this illness are relatively uncommon. (schmidtlaw.com)
  • Children in the poorest countries, however, suffer the greatest burden: more than 90 percent of deaths due to rotavirus occur in the developing world, where access to simple, lifesaving treatment is severely limited. (path.org)
  • Hospitalizations and deaths due to the rotavirus are relatively uncommon in the United States, where vaccinations are routinely administered to babies. (theclarkfirmtexas.com)
  • An inactivated adjuvanted vaccine for the vaccination of pregnant mares to stimulate the production of antibodies against Equine Rotavirus H2 serotype in colostrum and milk as an aid in the management of Rotavirus Enteritis. (theanimalpharmacy.com.au)
  • Unique specialist breeding vaccine for the vaccination of pregnant mares to provide passive transfer of antibodies to foals to reduce the risk of diarrhoea caused by Equine Rotavirus. (theanimalpharmacy.com.au)
  • Foals of the vaccinated mares show an increase in antibodies against Equine Rotavirus for approximately sixty days. (theanimalpharmacy.com.au)
  • The CDC recommends two vaccines during every pregnancy, the Flu vaccine and Tdap vaccine. (challiance.org)
  • International immunization programs for children have many vaccines in common but, depending on the region, may vary slightly. (medscape.com)
  • 2 , 5 Administration of acetaminophen at the time of vaccination or shortly afterward may alleviate some adverse effects, but there may be a decreased antibody response to some vaccine antigens in children who receive antipyretics. (aafp.org)
  • Epidemiological studies often provide the most important evidence as to whether a vaccine caused the problem because most adverse events are not unique clinical syndromes (that is, they also occur in people who did not receive the vaccine). (immunizationinfo.org)
  • Implementation of the U.S. rotavirus vaccination program reduced the annual proportion of positive rotavirus tests, reduced peak rotavirus activity, and shortened the duration of the rotavirus season. (cdc.gov)
  • It aims to help country-level policymakers compare products and estimate vaccination program costs for different rotavirus vaccines, exploring up to six different vaccine options at a time. (path.org)
  • Estimates of vaccine cost (i.e., vaccine and supplies procurement and international shipping) and vaccination program costs (i.e., vaccine cost and cost of delivery) are provided separately, based on limited user inputs, for two perspectives: (1) the country perspective and (2) the combined country and Gavi perspective (only relevant for Gavi-eligible countries). (path.org)
  • But it's an even more complex thing to think about how to introduce a vaccination program in the developing world for adolescents and adults. (princeton.edu)
  • Zoster vaccines. (medscape.com)
  • Note: ZVL has replaced the term HZV (herpes zoster vaccine) that was used in past adult immunization schedules to refer to the live zoster vaccine. (medscape.com)
  • Rotaviruses replicate mainly in the gut, where they infect cells in the small intestine. (sciencedaily.com)
  • Perhaps certain bacteria help the rotavirus replicate or antibiotics alter bacteria and thereby trigger immune responses that are favorable or unfavorable for a virus. (sciencedaily.com)
  • This is the largest genome known to exist within a rotavirus isolate and demonstrates the capacity of rotavirus to replicate and package large amounts of foreign sequence. (news-medical.net)
  • IA2030, endorsed by the World Health Assembly, includes a target to achieve 500 new and underutilized vaccine introductions in low-income and middle-income countries' routine immunization schedules by 2030. (medscape.com)
  • Year WHO recommended inclusion of vaccine in all national routine immunization programs. (medscape.com)
  • expenditures for vaccines and routine immunization is improving, but not all countries are reporting adequately. (who.int)
  • Government spending on immunization program sustainability to be perceived within average for routine immunization per live birth has now a broader and more comprehensive context. (who.int)
  • For Rotavirus, identify those for whom routine immunization is recommended. (cdc.gov)
  • Live oral rotavirus vaccines have been used to reduce its incidence in many countries. (news-medical.net)
  • METHODS: This retrospective study using Mexican National Databases of Health and population surveillance (2000-2019) assessed the incidence of pertussis, infant pertussis vaccination coverage, and vaccine effectiveness (VE) against clinically-diagnosed and/or laboratory-confirmed pertussis in children aged 6.5-18.5 or 24.5 months for the primary series, and children aged 18.5 or 24.5-48.5 months for the toddler booster. (bvsalud.org)
  • According to Zamboanga City Health Office, the city A line list of suspected cases was constructed from had a rotavirus outbreak in 2010 due to water contamina- records on suspected case patients admitted to the 11 tion, affecting around 500 individuals. (who.int)
  • The MMR footnote was updated to include guidance regarding the use of a third dose of mumps-containing vaccine during a mumps outbreak. (medscape.com)

No images available that match "program rotavirus vaccines"